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THESIS ABSTRACT 
 
 KCNE peptides are a class of type I transmembrane β-subunits that assemble with 
and modulate the gating and ion conducting properties of a variety of voltage-gated K+ 
channels. Accordingly, mutations that affect the assembly and trafficking of K+ 
channel/KCNE complexes give rise to disease. The cellular mechanisms that oversee 
KCNE peptide assembly with voltage-gated K+ channels have yet to be elucidated. In 
Chapter II, we show that KCNE1 peptides are retained in the early stages of the secretory 
pathway until they co-assemble with KCNQ1 K+ channel subunits. Co-assembly with 
KCNQ1 channel subunits mediates efficient forward trafficking of KCNE1 peptides 
through the biosynthetic pathway and results in cell surface expression.  
 KCNE1 peptides possess two N-linked glycosylation sites on their extracellular 
N-termini. Progression of KCNE1 peptides through the secretory pathway can be 
visualized through maturation of N-glycans attached to KCNE1. In Chapter III, we 
examine the kinetics and efficiency of N-linked glycan addition to KCNE1 peptides. 
Mutations that prevent glycosylation of KCNE1 give rise to the disorders of arrhythmia 
and deafness. We show that KCNE1 acquires N-glycans co- and post-translationally. 
Mutations that prevent N-glycosylation at the co-translational site have a long range 
effect on the disruption of post-translational glycosylation and suggest a novel biogenic 
mechanism for disease.  
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 In Chapter IV, we determine the presence of an additional post-translational 
modification on KCNE1 peptides. We define specific residues as sites of attachment of 
this modification identified as sialylated O-glycans and show that it occurs in native 
cardiac tissues where KCNE1 plays a role in the maintenance of cardiac rhythm.  
 Taken together, these observations demonstrate the importance of having 
correctly assembled K+ channel/KCNE complexes at the cell surface for their proper 
physiological function and define a role for the posttranslational modifications of KCNE 
peptides in the proper assembly and trafficking of K+ channel/KCNE complexes. 
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PREFACE 
 The work presented in Chapter II has been published in a peer-reviewed journal 
(Chandrasekhar et al. 2006). Tuba Bas generated the C-terminal HA-tagged construct of 
KCNE1 that was used in the whole cell immunofluorescence studies examining 
intracellular localization of KCNE1 peptides.  
 The experimental work in Chapter III has been written up as a manuscript for 
publication at the time of this thesis preparation. I performed the initial biochemical 
investigation to determine the contribution of N-linked glycosylation on the stability and 
expression of KCNE1 peptides. I examined protein expression and stability of several 
glycosylation-deficient mutations of KCNE1, in particular T7I that is associated with 
Long QT syndrome presentation. Chapter III describes the elegant kinetic studies of N-
linked glycosylation of KCNE1 peptides executed by Tuba Bas that were based on my 
preliminary biochemical observations. Tuba Bas is credited with first authorship on the 
manuscript for her significant work characterizing the process of N-glycosylation of 
KCNE1 and describing a novel mechanism for the biogenesis of Long QT syndrome. 
Authorship is also credited to Dr. Anatoli Lvov for the electrophysiological 
characterizations of the N-glycosylation deficient mutant E1 peptides.  
 In Chapter IV, the electrophysiological studies investigating the contribution of 
KCNE1 O-glycans to the function of KCNQ1/KCNE1 channel complexes were 
performed by Dr. Anatoli Lvov.  
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CHAPTER I 
INTRODUCTION 
 Potassium channels are involved in many functional aspects of human physiology 
in excitable and non-excitable cells – from the maintenance of cardiac rhythm, to salt-
water homeostasis in epithelial tissues, to neuronal action potential repolarization. The 
breadth of biological K+ channel function stems from the diversity of K+ channel 
complexes which is further increased by the association of channel subunits with soluble 
and transmembrane accessory proteins that modulate channel function.  
 Since a gene encoding a Kv channel was first cloned from Drosophila Shaker 
(Papazian et al. 1987; Tempel et al. 1987), over 40 voltage gated K+ (Kv) channels have 
been identified and studied extensively (Wulff et al. 2009). The Shaker-like channels 
have similar structural characteristics to Shaker and include the KCNQ family, hERG, the 
Shaker-related channels and Ca2+-activated K+ channels. The channels assemble as 
tetramers to generate the ion-conducting pore subunit of a K+ channel (MacKinnon 
1991). Each channel monomer  is composed of six transmembrane-spanning α-helices 
(S1-S6) with the voltage-sensing domain located in helices S1-S4 and the pore domain 
situated in S5-S6 with a pore loop (P-loop) between helices S5 and S6 (Fig. 1.1). 
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Figure 1.1 Cartoon representation of a Shaker-like K
+
 channel, KCNQ1. Left, 
schematic of Shaker-like K+ channel KCNQ1 based on the canonical transmembrane 
structure of a single Shaker subunit as viewed through the plane of the plasma membrane. 
The S1-S4 helices constitute the voltage sensing domain indicated in light blue. The S5 
and S6 helices connected with the pore loop make up the pore domain of the channel 
(purple). The N- and C-termini are shown as facing the intracellular cytoplasm. Right, 
schematic of tetrameric assembly of KCNQ1 K+ channel monomers to generate the pore-
forming subunit of the K+ channel.   
Schematic generated by K. Mruk. 
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KCNQ K
+
 channels 
 The gene for one Shaker-like channel, KCNQ1 (Q1), was identified by positional 
cloning of locus 11p15.5 on chromosome 11 from a family of individuals exhibiting the 
phenotype of elongated QT intervals on recorded EKGs and fainting episodes related to 
ventricular fibrillations (Wang et al. 1996). The KCNQ channel family was established 
with the discovery of KCNQ2-5 (Q2-Q5) channels (Charlier et al. 1998; Singh et al. 
1998; Wang et al. 1998; Yang et al. 1998; Kubisch et al. 1999; Lerche et al. 2000; 
Schroeder et al. 2000). Q1 channels are distributed throughout the body but are absent in 
the nervous system where Q2-Q5 are predominantly localized (Cooper and Jan 2003). 
Q2-Q5 channel subunits can assemble as homo- or heteromeric K+ channels (Schroeder 
et al. 1998; Wang et al. 1998; Kubisch et al. 1999; Schroeder et al. 2000; Bal et al. 2008).  
 On the other hand, Q1 subunits assemble only as a homotetramer forming rapidly 
activating K+ channels that achieve maximal conductance but also undergo channel 
inactivation in short periods of time (Barhanin et al. 1996; Sanguinetti et al. 1996; Pusch 
et al. 1998). Q1 currents have never been observed in native tissues such as cardiac 
myocytes and the epithelial cells of the lung, stomach, cochlea, intestine and kidney 
(Jespersen et al. 2005). In vivo, Q1 associates with small regulatory accessory proteins (β-
subunits) of the KCNE family to generate the β-subunit specific current characteristics 
that are observed physiologically (Barhanin et al. 1996; Sanguinetti et al. 1996; 
Schroeder et al. 2000; Tinel et al. 2000; Angelo et al. 2002; Grunnet et al. 2002). 
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KCNE peptides 
 The KCNE peptides are a β-subunit family of small type I single-transmembrane 
spanning proteins with an extracellular N-terminus. KCNE1 (E1) was the first cloned 
member of this family and had initially been assumed to be the K+ channel responsible 
for the cardiac delayed rectifier current (IKs) based on observations in Xenopus oocytes 
where injection of E1 RNA gave rise to IKs-like currents (Takumi et al. 1988). It was after 
the discovery of Q1 as the ion-conducting subunit of the IKs channel that E1 was 
designated the role of an accessory subunit in the IKs channel complex. Association of Q1 
with E1 alters the biophysical properties of the Q1 channel resulting in an increase in 
macroscopic current amplitude and slowed channel activation with a loss of channel 
inactivation (Barhanin et al. 1996; Sanguinetti et al. 1996; Splawski et al. 1997) (Fig. 
1.2). These characteristic biophysical properties of the Q1/E1 K+ channel complex are 
crucial to its role in cardiac myocytes where Q1/E1 channels generate IKs current for the 
repolarization of the action potential and in the inner ear where Q1/E1 complexes are 
involved in the regulation of salt-water homeostasis (Barhanin et al. 1996; Sanguinetti et 
al. 1996; Vetter et al. 1996; Lee et al. 2000; Wangemann 2002).  
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Figure 1.2 KCNQ1/KCNE1 channel complex. Transmembrane topology diagram of 
the KCNQ1/KCNE1 channel complex. For clarity, only two subunits of the Q1 tetramer 
are shown. Voltage-sensing and pore-forming domains, are colored cyan and purple, 
respectively; E1 is colored green. Extracellular and intracellular faces of the membrane 
are indicated as ‗out‘ and ‗in‘. KCNQ1 helices are numbered S1-S6 with the C-terminal 
S4-S5 linker shown interacting with a C-terminal helix of KCNE1. Branched structures 
on KCNE1 N-terminus indicate positions of N-glycan attachments. K+ flow (brown) 
denotes location of ion conducting pore within the fully assembled complex. 
Stoichiometry of the fully assembled complex is 4 KCNQ1 monomers with 2 KCNE1 
peptides. Bottom, families of currents recorded from Xenopus oocytes expressing 
KCNQ1 channels alone or KCNQ1/ KCNE1 channel complexes. Currents were elicited 
by a pulse protocol of 4 s step test potentials from –80 to +60 mV in 10 mV increments 
from a holding potential of –80 mV followed by a tail pulse to –30 mV (left). Dashed line 
indicates zero current. Scale bars represent 1 μA and 0.5 s. KCNQ1 channels undergo 
rapid activation and inactivation in the time period shown. KCNQ1/KCNE1 channel 
complexes are slowly activating with increasing amounts of current conducted over time. 
The I/V curve illustrates a right shift in voltage activation of KCNQ1 upon association 
with KCNE1 (right). 
Schematic adapted with permission from Lvov, A., Gage, S.D., Berrios, V.M. and 
Kobertz, W.R., Identification of a protein-protein interaction between KCNE1 and the 
activation gate machinery of KCNQ1. J. Gen. Physiol., 2010. 135(6): 607. 
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Current traces adapted with permission from Mruk , K. and Kobertz, W.R., Discovery of 
a novel activator of KCNQ1/KCNE1 K
+
 channel complexes. PLoS ONE, 2009. 4(1): 
e4236. 
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Cardiac action potential 
 The propagation of an action potential in cardiac myocytes requires the exquisite 
interplay between numerous Na+, Ca2+ and K+ channels. The timing and duration of the 
cardiac action potential is tightly regulated resulting in rapid depolarization and slow 
repolarization of cardiac myocytes (Roden et al. 2002). The length of an action potential 
is on the order of ~200-300 milliseconds, a necessary delay that allows for the normal 
excitation-contraction phase in myocytes and renders them insensitive to premature 
excitatory signals.  K+ conducting channels such as Q1 and hERG generate IKs and IKr 
currents respectively and are involved in the long ventricular repolarization phase which 
allows for the re-equilibration of myocytes to their resting potentials in preparation for 
the next action potential depolarization (Fig. 1.3). A prolongation or delay in the 
ventricular repolarization phase is associated with a class of inherited genetic disorders, 
the Long QT syndromes (LQTS). This delay is measured as an elongation in the QT 
interval on an EKG, and leads to early-after-depolarizations that can trigger syncopal 
attacks and ventricular tachycardia causing arrhythmias and sudden death (Ackerman and 
Clapham 1997; Sanguinetti and Spector 1997; Chiang and Roden 2000). Congenital 
LQTS is associated with mutations in a variety of ion channels that affect their normal 
functioning and is characterized as LQT1 through LQT6 based on the ion channel genes 
involved.  Mutations in the Q1 channel and E1 peptides that reduce channel current are 
associated with LQT1 and LQT5, respectively.  
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Figure 1.3 Cardiac action potential. Above, depiction of a cardiac action potential and 
the ion channel currents associated with each phase. Below, schematic representation of 
surface electrocardiogram (EKG) of the electrical events occurring within the heart. The 
P wave reflects atrial depolarization, the QRS complex reflects ventricular depolarization 
and the T wave is indicative of ventricular repolarization. Elongation of the QT interval is 
associated with Long QT syndrome. 
Schematic generated by K. Chandrasekhar.  
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 The autosomal dominant form is known as Romano-Ward syndrome (RWS) and 
results from nonfunctional mutant channels inhibiting their wild type subunit counterparts 
from normal alleles resulting in severe cardiac dysfunction (Romano et al. 1963; Ward 
1964; Chouabe et al. 1997; Sanguinetti 1999; Hoppe et al. 2001). The autosomal 
recessive disease is Jervell and Lange-Nielsen syndrome (JLNS), which in its 
homozygous form displays both cardiac dysfunction and bilateral deafness (Jervell and 
Lange-Nielsen 1957; Neyroud et al. 1997; Schulze-Bahr et al. 1997; Splawski et al. 1997; 
Splawski et al. 2000).  
 Biophysical characterization of genetic mutations in either member of the Q1/E1 
channel complex reveals mechanisms by which LQTS occurs. For example, S74L, 
D76N, V47F and W87R are mutations identified in E1 that cause RWS (Schulze-Bahr et 
al. 1997; Splawski et al. 1997; Duggal et al. 1998). S47L co-assembles with Q1 channels 
to form IKs-generating channels with altered biophysical properties. The S74L mutation 
results in a right shift of the midpoint of activation and increases the rate of channel 
deactivation. Co-expression of Q1 with D76N mutant E1 produces non-conducting 
channel complexes as the presence of one mutant peptide in the channel complex is 
sufficient to disrupt normal function (Splawski et al. 1997). V47F and W87R result in 
decreased current amplitude and an alteration of the gating kinetics of the Q1/E1 channel 
complex (Bianchi et al. 1999).  
 While biophysical data give us a handle on how LQTS-associated mutations 
affect channel function, biochemical characterization is also used to determine whether 
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current reduction is a result of improper biosynthetic processing of the Q1/E1 channel 
complex. For example, L51H is a JLNS-associated mutation in the transmembrane 
domain of E1 (Bianchi et al. 1999; Krumerman et al. 2004). In the Xenopus oocyte 
expression system, Q1/L51H E1 complexes did not produce Q1/E1-like currents (Bianchi 
et al. 1999). In human embryonic kidney (HEK) 293 cells, immunofluorescence staining 
of L51H in the absence or presence of Q1 channels revealed that L51H E1 peptides were 
largely retained in the endoplasmic reticulum (ER) and did not traffic to the cell surface 
(Krumerman et al. 2004). Additionally, currents produced by the co-expression of Q1 
with L51H E1 were biophysically similar to Q1 channels expressed alone suggesting 
impaired assembly of the channel complex (Bianchi et al. 1999; Krumerman et al. 2004). 
Other RWS and JLNS-associated mutations have been identified by the genetic screening 
of LQTS-affected families but have yet to be characterized biochemically or functionally 
(Splawski et al. 2000; Ackerman et al. 2003; Lai et al. 2005; Napolitano et al. 2005; Shim 
et al. 2005).  
 
K
+
 ion homeostasis in the inner ear 
 The endolymph of the inner ear is an extracellular fluid where the predominant 
cationic species are K+ ions involved in sensory transduction of the cochlea and the 
vestibular labyrinth (Fig. 1.4). Sensory transduction requires the flow of K+ ions from the 
endolymph into the perilymph and back. This cyclical process maintains the high K+ ion 
concentration in the endolymph. Q1 co-assembles with E1 in the stria vascularis to form  
12 
 
 
 
Figure 1.4 Ion transport in the inner ear. The balance of activities of various ion 
channels and ion transporters in the inner ear. The KCNQ1/KCNE1 K+ channel complex 
located in the stria vascularis cells provides the sole pathway for the transport of K+ ions 
to the endolymph fluid. K+ ion homeostasis in the endolymph is necessary for sensory 
transduction. 
Figure and figure legend adapted from Hunter, M., Ion channels: Accessory to kidney 
disease. Nature, 2001. 414 p. 502-503 
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K+ channels responsible for the reabsorption of K+ ions to the endolymph in the inner ear 
(Neyroud et al. 1997; Nicolas et al. 2001; Wangemann 2002).  
 The importance of the Q1/E1 channel complex in inner ear K+ ion homeostasis 
was demonstrated in genetically altered mice that were lacking either Q1 or E1 protein, 
or carrying mutations in one or both proteins. In kcne (-/-) knockout mice, the 
endolymphatic space appears normal early in development. However, at postnatal day 3, 
gross morphological changes are apparent with an increase in size of the vestibular cells 
and collapse of the endolymphatic space because of an inability of the strial marginal 
cells to recycle K+ ions to the endolymph (Nicolas et al. 2001). As a result, the kcne (-/-) 
knockout mice as well as mice expressing mutant Q1 or E1 showed severe symptoms of 
deafness (Vetter et al. 1996; Lee et al. 2000; Letts et al. 2000; Casimiro et al. 2001). 
Additionally, it was observed that in the vestibular dark cells of kcne (-/-) mice, Q1 
protein was mislocalized to the cytoplasm rather than trafficking to the appropriate apical 
surface (Nicolas et al. 2001). Hence, the assembly of Q1 with E1 is necessary for the 
correct cellular trafficking and proper functioning of the channel complex in native cells. 
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Assembly of KCNQ1/KCNE channel complexes 
 Trafficking-deficient mutations associated with LQTS have been identified in 
both Q1 and the KCNEs (Bianchi et al. 1999; Yamashita et al. 2001; Gouas et al. 2004; 
Krumerman et al. 2004; Wilson et al. 2005; Harmer et al. 2010), highlighting the role of 
cellular quality control mechanisms in ensuring that correctly assembled channel 
complexes migrate to the plasma membrane. There are two cellular locations where 
Q1/KCNE co-assembly was proposed to be mediated – the plasma membrane and the 
ER. The plasma membrane-based assembly of Q1/KCNE channels was hypothesized by 
Grunnet et al. based on observations where injection of KCNE4 (E4) mRNA into oocytes 
expressing Q1 channels mediated a measureable change in recorded currents as a result 
of association of E4 peptides with Q1 channels already present at the plasma membrane 
(Grunnet et al. 2002). Additionally, the cellular distribution of Q1 channels in the 
presence and absence of KCNE peptides was determined by immunofluorescent labeling. 
Since the lifetimes of the cell surface expressed Q1/KCNE channel complexes were not 
measured in this study, it is also possible that channel complex turnover at the cell 
surface contributed to the observed current changes.  
 The ER-based assembly of Q1/E1 channel complexes was proposed by the 
observation that immature glycosylated E1 peptides associated with Q1 (Krumerman et 
al. 2004). In this study, the ER-retention and trafficking of E1 mutant peptides was 
biochemically characterized in HEK cells. HEK cells are a useful over-expression system 
for the biochemical characterization of various proteins. However, HEK cells have been 
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shown to contain endogenous Kv channels (Jiang et al. 2002) that can associate with E1 
peptides (Lewis et al. 2004). Hence, HEK cells are not a good system in which to study 
E1 trafficking. Additionally, the detection of unglycosylated E1 on the cell surface in this 
study does not clearly show how Q1/E1 complex formation is regulated within cells. 
Nonetheless, the ER-based assembly hypothesis did signify the importance of regulation 
of Q1/E1 complex formation early in the biosynthetic pathway. Since unpartnered Q1 
channels cannot generate the appropriate currents for IKs and K
+ ion recycling in the inner 
ear, correct Q1/E1 complex formation is necessary for their proper channel function in 
native cells.  
 The subunit stoichiometry between Q1 channels and E1 peptides has been subject 
to debate over the years. Q1 and E1 subunit mixing experiments suggested a two-fold or 
four-fold symmetry of subunit assembly with either 2 or 4 E1 peptides associating with 4 
subunits of the Q1 channel (Wang and Goldstein 1995). In whole cell patch recordings, 
Q1 channel modulation was altered as a function of increasing concentrations of E1 
suggesting that multiple stoichiometries for Q1/E1 assembly were possible (Wang et al. 
1998). More recently, the charybdotoxin sensitivity of naturally assembled Q1/E1 
channel complexes was compared to concatenated Q1/E1 counterparts of forced 
stoichiometries (Chen et al. 2003). This study determined that 2 E1 subunits assembled 
with a Q1 tetramer to form functional K+ channel complexes. However, the possibility of 
multiple stoichiometries could not be ruled out. The use of a chemically modified 
charybdotoxin K+ channel inhibitor confirmed that only 2 E1 subunits associated with 4 
Q1 subunits to generate a functional Q1/E1 channel complex (Morin and Kobertz 2008). 
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The exact order of subunit association in the Q1/E1 channel complex and the cellular 
mechanisms that regulate the assembly process in native tissues are yet to be determined. 
 The process of Q1/E1 assembly in commonly used over-expression systems like 
Xenopus oocytes, HEK, Chinese hamster ovary (CHO) and African green monkey kidney 
(COS-7) cells is not tightly regulated for unpartnered Q1 channels. Homotetrameric Q1 
channels can traffic efficiently and function at the cell surface in the absence of a KCNE 
partner (Pusch et al. 1998; Tinel et al. 2000; Melman et al. 2001). In Xenopus oocytes, 
Q1 mutants containing the R243C and W248R substitutions in the S4-S5 linker region 
form functional channels when expressed alone; however co-expression of these mutant 
Q1 channels with wild type E1 peptides suppressed current (Franqueza et al. 1999). Since 
E1 subunits are believed to associate closely with the S4-S5 linker region (Kang et al. 
2008), it is possible that the loss of function observed on mutant Q1 assembly with E1 
peptides was caused by the aberrant trafficking of improperly assembled channel 
complexes. However, in native cell types, Q1/KCNE complex assembly appears to be 
regulated. In kcne1 (-/-) mice, the apical localization of Q1 in the vestibular dark cells of 
the inner ear is disrupted in the absence of E1 protein (Nicolas et al. 2001). 
 The regulation of E1 trafficking is not well understood because the presence of 
endogenous K+ channels in some heterologous systems muddles the interpretation of 
biochemical and electrophysiological studies of LQTS-associated E1 mutants (Bianchi et 
al. 1999; Krumerman et al. 2004). In Chapter II, we attempt to resolve this issue by 
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comparing the trafficking of solitary and channel-partnered E1 peptides in a panel of 
over-expression systems typically used in the field.  
 
Glycosylation of KCNE peptides 
 The KCNE family of peptides exhibits a high degree of sequence homology, with 
one or more putative N-linked glycosylation consensus sites in the N-terminal region of 
the peptides (Fig. 1.5). The positioning of the N-linked glycosylation sites in the KCNE 
family are conserved in various species, in particular the site in close proximity to the N-
terminus. Genetic analysis of a family exhibiting LQTS symptoms revealed a T7I 
mutation in E1 that is associated with JLNS (Schulze-Bahr et al. 1997). The T7I amino 
acid substitution prevents the addition of N-glycans to the N5 site in the consensus 
sequence (N-T-T). Similarly, a single nucleotide polymorphism in KCNE2 that results in 
the T8A mutation prevents N-glycosylation at N6 and is associated with drug-induced 
LQTS (Larsen et al. 2001; Lu et al. 2003). Functional effects of the removal of N-linked 
glycosylation sites on E1 peptides has been shown in Xenopus oocytes as an abolishment 
in channel activity (Takumi et al. 1991). In spite of these observations, the exact 
relationship between KCNE glycosylation and LQTS presentation is not currently well 
understood. In Chapter III, we determine the importance of N-linked glycosylation of E1 
peptides and suggest a mechanism by which T7I is involved in LQTS presentation. 
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Figure 1.5 KCNE peptides. Left, schematic of the transmembrane topology of KCNE1 
(E1) with extracellular N-glycan attachment sites denoted by branched structures. Right, 
amino acid alignment of members of the KCNE family. The N-glycosylation consensus 
sequences in each peptide are underlined in red; TM domain indicates the residues within 
the transmembrane region; conserved residues are colored in grey.  
Schematic of KCNE1 peptide generated by K. Chandrasekhar. Amino acid alignment 
adapted from McCrossan, Z.A. and Abbott, G.W., The MinK-related peptides. 
Neuropharmacology, 2004. 47(6):p. 787-821  
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 Glycosylation is characterized by the enzyme-mediated addition of carbohydrate-
rich glycans to proteins. The process of glycan addition to proteins is shared by the ER 
and Golgi compartments (Helenius and Aebi 2004). N-linked (or Asparagine-linked) 
glycosylation is a protein modification that is unique to the ER and often important for 
the primary ER quality control of glycoprotein assembly (Ellgaard and Helenius 2003). 
N-linked glycosylation is the process of coupling of a core N-glycan to nascent 
polypeptides. The core N-glycan is a 14-residue precursor oligosaccharide group 
composed of three glucoses, nine mannoses, and two N-acetyl glucosamine residues 
(Glc3Man9GlcNAc2). The core N-glycan assembly is initiated in the cytosol by the 
addition of monosaccharides to a dolichol pyrophosphate carrier molecule by multiple 
monosaccharyltransferases (Fig. 1.6). Core N-glycan assembly is terminated in the ER 
when the dolichol pyrophosphate ‗flips‘ its orientation in the ER membrane and exposes 
its 7-residue intermediate N-glycan to monosaccharyltransferases in the ER lumen that 
load the remaining sugars onto the core N-glycan (Burda and Aebi 1999). In the ER, an 
oligosaccharyltransferase (OST) complex associated with the translocon scans the 
nascent polypeptide chain emerging into the ER lumen for the N-glycosylation consensus 
sequence Asn-X-Thr/Ser (NXT/S) where X is any amino acid except proline (Bause 
1983; Silberstein and Gilmore 1996). When OST recognizes this sequence on the 
polypeptide chain, it immediately catalyzes the transfer of the core N-glycan from the 
lipid carrier to the nascent polypeptide through an N-glycosidic bond on the side chain of 
the asparagine residue in the consensus sequence. ER chaperones like calnexin and 
calreticulin, which oversee the folding and assembly of glycosylated channels use these  
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Figure 1.6 Cartoon of N-linked oligosaccharide and N-glycan modification through 
the biosynthetic pathway. Above, component sugars of the core N-linked glycan that is 
attached to a nascent polypeptide through an N-glycosidic bond at an Asn-X-Ser/Thr 
consensus site. Terminal glucose and mannose residues are removed in the ER by 
glucosidase and mannosidase enzymes. Symbols for the different sugars are shown in the 
legend. Below, biosynthesis of core N-glycan. Synthesis depicted from the initial addition 
of sugars to the dolichol pyrophosphate in the cytoplasm to the completed core N-glycan 
in the ER. Oligosaccharyltransferase complex catalyzes N-glycan transfer to the nascent 
polypeptide as it enters the ER lumen through the translocon. Three terminal glucose 
residues are removed by ER glucosidases I and II and the polypeptide is allowed to 
undergo folding/assembly till it reaches its native structure. Subsequent trimming of a 
mannose sugar allows protein migration from the ER to the Golgi compartment. Various 
glycan modification reactions are catalyzed in the Golgi; only one of many sugar 
trimming and addition pathways is shown. Terminal glycosylation results in the addition 
of GlcNAc, galactose, fucose, and sialic acid sugars to N-glycans. While glycoforms in 
the ER are homogenous, the Golgi-generated forms are usually diverse and varied owing 
to the multiple N-glycan modification pathways. 
Figures and figure legends adapted from Helenius, A. and Aebi, M., Intracellular 
Functions of N-linked Glycans. Science, 2001. 291 p. 2364-2369   
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glycan ‗handles‘ on individual channel subunits to facilitate oligomeric assembly 
(Helenius and Aebi 2001; Helenius and Aebi 2004). Association with chaperones is 
important for the stability of channel subunits in the ER, as observed for the Shaker K+ 
channel (Papazian 1999; Khanna et al. 2001; Khanna et al. 2004). Chaperone assembly 
with glycosylated polypeptides occurs after the cleavage of two terminal glucose residues 
from the core N-glycan by ER glucosidases I and II (Ellgaard and Helenius 2001; 
Ellgaard and Helenius 2003). A cycle of de-and re-glucosylation of N-glycans occurs 
until the polypeptide assumes its native assembled state. The core N-glycans can be 
further modified in the Golgi compartments where trimming and addition of sugar 
residues results in the maturation of the N-glycan attached to the nascent protein.  
 Endoglycosidases are glycan-specific enzymes used to cleave specific sugar 
residues from glycoproteins facilitating their identification. Differential sensitivity of N-
glycans to various glycosidases can be used as markers to determine the cellular location 
of glycoproteins in the biosynthetic pathway. Two endoglycosidases, Endo H and 
PNGase F, have been used in the biochemical characterization of glycans on ion channels 
(Khanna et al. 2004; Krumerman et al. 2004). Endo H is an endoglycosidase that cleaves 
high mannose and some hybrid types of N-glycans such as those predominantly found in 
the ER while PNGase F cleaves almost all forms of N-glycans found throughout the 
secretory pathway. In Chapter II, we accurately define the glycosylation states of E1 
peptides in the presence and absence of K+ channel partners using the Endo H and 
PNGase F sensitivities of glycans on E1 as a means to examine the trafficking 
competency of E1 peptides.  
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 Historically, N-glycosylation has been considered a co-translational process 
catalyzed by OST as the nascent polypeptide is threaded through the translocon. 
However, recent evidence using two different glycoprotein substrates suggests that post-
translational N-glycosylation can also normally occur on glycoproteins containing 
multiple N-glycosylation consensus sites (Bolt et al. 2005; Lambert and Prange 2007). 
Ruiz-Canada et al. determined that there are two hetero-oligomeric forms of OST that can 
individually catalyze the co- and post-translational addition of N-glycans when 
glycoproteins contain multiple consensus sequences (Ruiz-Canada et al. 2009). In 
Chapter III, we investigate the process of N-glycan addition to nascent E1 peptides to 
determine the relative importance of each of the two N-glycosylation sites on E1 on 
overall protein stability and trafficking efficiency. Our findings suggest a mechanism by 
which glycosylation deficiency may be implicated in LQTS. 
 Unlike N-linked glycosylation which is initiated in the ER as a co-translational 
process, O-linked glycosylation is a post-translational protein modification. O-linked 
glycosylation has been thought to occur typically in the Golgi compartment although the 
enzymes catalyzing O-glycan transfer have been detected as early as the ER (Roth et al. 
1986). While N-glycan attachment is characterized by the presence of consensus 
sequences on target proteins, O-glycan attachment is not dependent on the presence of 
specific consensus sites on proteins. In theory, all extracellularly exposed serine and 
threonine residues are potential O-glycan linkage sites; however, only certain residues are 
efficiently O-glycosylated based on the hydrophobicity and nature of residues 
surrounding the O-glycan attachment sites (Van den Steen et al. 1998). Predictive 
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algorithms can be used in determining potential O-linkage sites on a protein. The 
NetOGlyc3.1 server is an algorithm that uses structural and amino acid environmental 
information for O-glycan attachment from known O-glycosylated proteins to predict the 
likelihood of O-glycosylation at certain residues in an input amino acid sequence 
(Julenius et al. 2005). The process of O-glycan attachment on proteins is catalyzed by 
nucleotide sugar transporters which carry sugar groups to organelles where 
glycosyltransferases mediate the transfer of sugars to serine or threonine residues on 
proteins (Hirschberg et al. 1998). Structurally, O-glycans acquire diverse configurations 
of sugars owing to the multiple glycosyltransferases that catalyze the addition of different 
residues to growing O-glycan branches. In the trans-Golgi, O-glycans acquire terminal 
sialic acid residues that crown the carbohydrate chains (Roth et al. 1986).  
 Disruption of the cell surface glycosylation of cardiac ion channels has been 
implicated in ion channel dysfunction. Terminal sialic acid residues on N- and O-glycan 
modifications create a cloud of negative charge close to the membrane surface that 
impacts the positively charged voltage-sensing domains in ion channels. Voltage-sensing 
domain movement can trigger the opening and closing of channels in response to 
membrane depolarization. Ufret-Vincenty et al. show that the absence of glycosylation in 
voltage-gated Na+ channels shifts the voltage dependence of activation and inactivation 
of the channels which recapitulates the phenotype observed in Na+ channel 
arrhythmogenesis heart failure (Ufret-Vincenty et al. 2001). This study suggests that the 
negatively charged sialic acid residues can affect the voltage dependence of the channel 
based on a surface potential model where the presence of negative charge close to the 
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membrane affects its surface potential and thereby exerts an effect on the threshold of 
activation of the channel (Green and Andersen 1991). 
 The significance of glycosylation in channel function is not limited to Na+ 
channels. Similar work on the Kv4.3 channel showed that channel glycosylation plays a 
significant role in the generation of the transiently-outward cardiac current (Ito) and that 
improper channel glycosylation leads to arrhythmogenic changes to this current (Ufret-
Vincenty et al. 2001). Glycosylation of ancillary subunits has also been shown to be 
important in the modulation of Na+ and K+ channel function. Similar to E1, the β1 
subunit of the Nav channel complex is a single transmembrane-spanning protein with N-
glycan attachment sites in its extracellular N-terminus. When its N-glycans are fully 
sialylated, the β1 subunit modulates channel gating by left shifting the midpoint of 
activation (V1/2) to hyperpolarizing potentials (Johnson et al. 2004). In Chapter IV, we 
determine whether E1 peptides acquire sialylated O-glycans as a post-translational 
modification and discuss their potential role in Q1/E1 channel function.  
 The KCNE peptides are one class of β-subunits that associate with and modulate 
K+ channels in a variety of tissues. The work presented in this thesis introduces the 
cellular mechanisms underlying assembly and trafficking of a specific Q1/KCNE K+ 
channels – the Q1/E1 complex. The study of E1 trafficking can be applied to investigate 
the cellular trafficking of other K+ channel/KCNE β-subunits. Additionally, the role of β-
subunit glycosylation in the stability and functional modulation of K+ channels enhances 
our understanding of how glycosylation can be implicated in ion channel dysfunction. N-
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linked glycosylation is conserved throughout the KCNE family and mutations that disrupt 
the addition of N-glycans to KCNE peptides are associated with disease (Larsen et al. 
2001; Lu et al. 2003; Park et al. 2003). Investigating the process of N-glycan addition to 
KCNE peptides could reveal novel mechanisms by which N-glycosylation defects are 
linked to LQTS. Lastly, the discovery of O-linked glycosylation on E1 peptides suggests 
additional roles for post-translational modifications on KCNE peptides in the stability 
and function of K+ channel/KCNE complexes. 
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CHAPTER II 
KCNE1 PEPTIDES REQUIRE CO-ASSEMBLY WITH SPECIFIC K
+
 CHANNELS 
FOR EFFICIENT TRAFFICKING AND CELL SURFACE EXPRESSION 
 
 
ABSTRACT 
 KCNE peptides are a class of type I transmembrane β-subunits that assemble with 
and modulate the gating and ion conducting properties of a variety of voltage-gated K+ 
channels. Accordingly, mutations that disrupt the assembly and trafficking of KCNE-K+ 
channel complexes give rise to disease. The cellular mechanisms responsible for ensuring 
that KCNE peptides assemble with voltage-gated K+ channels have yet to be elucidated. 
Using enzymatic deglycosylation, immunofluorescence, and quantitative cell surface 
labeling experiments, we show that KCNE1 (E1) peptides are retained in the early stages 
of the secretory pathway until they co-assemble with specific K+ channel subunits; co-
assembly mediates E1 progression through the secretory pathway and results in cell 
surface expression. We also address an apparent discrepancy between our results and a 
previous study in human embryonic kidney cells, which showed wild type E1 peptides 
can reach the plasma membrane without exogenously expressed K+ channel subunits. By 
comparing E1 trafficking in three cell lines, our data suggest that the errant E1 trafficking 
observed in human embryonic kidney cells may be due, in part, to the presence of 
endogenous voltage-gated K+ channels in these cells. 
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INTRODUCTION 
 Voltage-gated K+ channels have diverse physiological roles ranging from 
repolarization of excitable tissues to salt and water homeostasis in epithelial cells. To 
achieve such functional diversity, many K+ channels function as membrane-embedded 
complexes made up of pore-forming α-subunits and tissue specific regulatory β-subunits. 
The KCNE type I transmembrane peptides are a class of small β-subunits that assemble 
with and modulate the function of several types of voltage-gated K+ channels 
(McCrossan and Abbott 2004). E1 is the founding member of the family and has been 
shown to form complexes with Kv3.1, Kv3.2, Kv4.2, Kv4.3, HERG and KCNQ1 (Q1) K
+ 
channels (Barhanin et al. 1996; Sanguinetti et al. 1996; McDonald et al. 1997; Zhang et 
al. 2001; Deschenes and Tomaselli 2002; Lewis et al. 2004). When E1 assembles with 
Q1, the complex produces the slowly activating cardiac IKs current and is the exclusive 
pathway for endolymphatic K+ recycling in apical membranes of strial marginal and 
vestibular dark cells (Marban 2002; Wangemann 2002). Conversely, unpartnered Q1 
channels are ill-equipped to perform either function because they open and close too 
quickly to maintain the rhythmicity of the heartbeat and are significantly inactivated and 
non-conducting at the resting membrane potential of inner ear cells (Pusch et al. 1998). 
The biological importance of proper Q1/E1 complex formation is further underscored by 
the inherited mutations in either Q1 or E1 that disrupt the assembly and/or trafficking of 
the complex and give rise to cardiac arrhythmias, most notably long QT syndrome 
(Splawski et al. 2000). An autosomal recessive form of long QT syndrome also causes 
neural deafness (Tyson et al. 2000).  
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 Although proper K+ channel function requires completely assembled complexes 
at the plasma membrane, the cellular mechanisms that ensure K+ channel α-subunits 
combine with membrane-embedded β-subunits are starting to be elucidated. For the 
ATP-sensitive K+ channels (Kir6.1 and 6.2), which assemble with sulfonylurea receptors 
(sulfonylurea receptors 1/2A/2B) in a 4:4 stoichiometry, unpartnered channel and 
receptor subunits are stringently held in the endoplasmic reticulum (ER) via a RXR 
retention signal (Zerangue et al. 1999). Once an octomeric complex is formed, the KATP-
sulfonylurea receptor complex is permitted to exit the ER and traffic to the cell surface.  
 In contrast, E1 subunits in complexes with voltage-gated K+ channels may traffic 
differently than their KATP counterparts. Two different studies suggest that Q1/E1 
complex formation occurs at the plasma membrane, which would require both proteins to 
traffic through the secretory pathway independently (Romey et al. 1997; Grunnet et al. 
2002). More recently, it was proposed that Q1/E1 assembly occurs in the ER because 
mutant E1 proteins could retain Q1 channels there (Krumerman et al. 2004). However, 
unpartnered wild type E1 proteins freely exited the ER and migrated to the cell surface, 
an observation inconsistent with an ER-based assembly. A significant caveat with all of 
the above studies was that KCNE trafficking was studied in either Xenopus oocytes or 
human embryonic kidney (HEK) 293B cells, both of which possess endogenous 
transcripts of voltage-gated K+ channels that have been shown to assemble with KCNE 
subunits (Sanguinetti et al. 1996; Jiang et al. 2002).  
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 Here we examine the assembly and trafficking of wild type E1 subunits in the 
presence and absence of Q1 channels in Chinese hamster ovary (CHO) and African green 
monkey kidney (COS-7) cells, both of which are revered for their ‗electrical tightness‘ or 
lack of measurable endogenous K+ currents. Using these cells, we find that the majority 
of E1 protein is localized to the ER when expressed alone. Co-expression with Q1 
subunits promotes E1 protein trafficking through the secretory pathway, resulting in 
robust cell surface expression. Moreover, these results demonstrate that Q1/E1 complex 
formation occurs early in the secretory pathway and that unpartnered E1 subunits do not 
efficiently progress past the ER and cis-Golgi compartments until they assemble with Q1 
channel subunits. 
 
RESULTS 
 Active retention of unassembled membrane protein subunits is one mechanism by 
which a cell ensures that membrane-embedded K+ channel complexes are properly 
assembled before the proteins arrive at their final cellular destination (Ellgaard and 
Helenius 2003). Distinguishing cellular markers for ER-resident proteins are immature 
N-linked glycans. The ER utilizes these high mannose oligosaccharide handles to 
promote protein folding, oligomerization, quality control, retention, and trafficking 
(Helenius and Aebi 2001). Once N-linked glycoproteins reach the Golgi, however, they 
are no longer subject to the rigorous quality control systems of the ER and migrate 
through medial and trans-Golgi compartments relatively unabated while acquiring 
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complex modifications to their N-linked glycans (Helenius and Aebi 2001). Because 
KCNE peptides have two well conserved N-linked glycosylation consensus sites, we 
utilized this hallmark of ER residency to determine the cellular locales of E1 peptides 
expressed alone, with Q1, and with KCNQ4 (Q4), a K+ channel previously shown not to 
assemble with E1 (Fig. 2.1) (Melman et al. 2004). Transient expression of E1 alone in 
CHO cells gave rise to two strong bands at 16 and 22 kDa (though faint, higher molecular 
mass bands can be seen on this intentionally well developed, but not overexposed 
Western blot). When expressed with Q4, a similar banding pattern was observed with an 
additional band at 19 kDa. In contrast, expression with Q1 affords an additional, higher 
molecular mass band at ~40 kDa. The presence of this 40-kDa band was independent of 
the detergent lysis mixture used but only occurred in abundance when E1 was co-
expressed with Q1. The abundance of the higher molecular mass form of E1 was 
dependent on the ratio of Q1/E1 DNA used for transient transfection. Limiting amounts 
of Q1 DNA yielded all three forms of E1 protein as shown in Fig. 2.1; optimizing the 
Q1/E1 DNA ratio (Experimental Procedures) afforded primarily the higher molecular 
mass species (Fig. 2.2; see also Fig. 2.6). We also observed the same gel banding patterns 
for E1 in COS-7 cells (Fig. 2.1). 
 The multiple bands and differences in gel shift mobility suggested that E1 
peptides were differentially glycosylated depending on the presence of specific K+  
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Figure 2.1 KCNE1 peptides migrate differently on denaturing gels when expressed 
with specific K
+ channel subunits. Immunoblots of HA-tagged E1 peptides from 
solubilized CHO cells or COS-7 cells transfected with Q1, E1, Q1/E1, or Q4/E1 DNA. 
Expression of E1 alone or with Q4 yields two intense bands at 16 and 22 kDa in CHO 
cells and one band at 22 kDa in COS-7 cells. Q1/E1 co-expression results in the 
appearance of an equally strong band at ~40 kDa. Q1 was transfected alone to serve as a 
negative control.  
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channel subunits. We therefore determined whether the gel shift mobility difference that 
was observed with Q1/E1 co-expression was due to maturation of the glycans on E1. The 
maturity of N-linked glycoproteins can be readily determined using two different 
glycosidases. EndoH is a glycosidase that removes the high mannose (immature) glycans 
found on ER and cis-Golgi proteins but is unable to process the complex (mature) 
glycoforms once the protein reaches the medial Golgi in the biosynthetic pathway. In 
contrast, PNGase F is an endoglycosidase that removes all N-linked oligosaccharides. 
Treatment of the E1 samples with either Endo H or PNGase F reduced the 22 kDa band 
to 16 kDa, consistent with the loss of two immature glycans (Fig. 2.2). Thus, when E1 is 
expressed alone, the majority of the N-linked glycan is immature; indicating that 
unpartnered E1 is localized to the ER and/or cis-Golgi. Enzymatic deglycosylation of the 
Q1/E1sample afforded a different result. Treatment with Endo H had no effect on the 
higher molecular mass band. However, the two faint bands centered at ~20 kDa collapsed 
to the unglycosylated form (16 kDa), identifying these two bands as E1 glycoproteins 
with one and two immature glycans. Heating the samples (95°C for 5 min) did not affect 
any of the bands, suggesting that the higher molecular mass band was not due to protein 
aggregation. All of the glycosylated forms of E1, however, were susceptible to PNGase F 
treatment, indicating that the higher molecular mass form of E1 possessed mature N-
linked oligosaccharides. Because maturation of N-linked glycoproteins occurs in the 
medial and trans-Golgi, the presence of mature glycans in only the Q1/E1 sample shows 
that co-assembly with Q1 facilitates E1 peptide progression through the secretory 
pathway. Although the PNGase F-treated E1 protein was deglycosylated, several residual  
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Figure 2.2 KCNE1 glycopeptides are predominately immature until they assemble 
with KCNQ1 subunits. Immunoblot of enzymatic deglycosylation of E1 N-linked 
glycopeptides in the presence and absence of expressed Q1. The samples were left 
untreated (–), heat-treated (Δ) to 95°C for 5 min, digested with Endo H, or PNGase F and 
separated by SDS-PAGE (15%). Mature, immature, and unglycosylated (unglyc) samples 
are indicated as determined by enzymatic deglycosylation. Asterisks (*) denote PNGase 
F digestion products that consistently migrated slower than immature and unglycosylated 
protein, which may be due to an additional post-translational modification.
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bands were observed (indicated by the asterisks). Prolonged treatment with PNGase F, 
the addition of more enzyme, varying the concentration of SDS in the gel loading buffer, 
or heat denaturation did not change the intensity or mobility of these bands (data not 
shown). The residual banding is not partial digestion of the individual N-linked glycans 
because PNGase F directly cleaves the oligosaccharide from the peptide backbone (Lemp 
et al. 1990). It is possible that one of the two mature N-linked glycans on E1 is totally 
inaccessible to the enzyme; however, we have observed these similar bands with PNGase 
F-treated E1 mutants that possess only one N-linked glycosylation site (data not shown). 
These bands do not correspond to immature E1, because they have a slightly slower 
mobility that can be readily observed in either the E1 or the Q1/E1 PNGase F-treated 
samples. Moreover, PNGase F treatment of the E1 sample demonstrates that this enzyme 
cleaves both immature N-linked glycans efficiently. These additional bands were also 
resistant to a subsequent phosphatase treatment (Fig. 2.3). We also confirmed that 
ubiquitin modifications were absent on mature E1 peptides (Fig. 2.4) so these additional 
bands may be due to the presence of another type of post-translational modification. 
 Because maturation of N-linked glycans on E1 requires co-expression with Q1, 
we determined whether cell surface expression of E1 was also dependent on expression 
with specific K+ channel subunits. Cell surface expression of E1 protein was visualized 
by immunofluorescence with permeabilized and non-permeabilized cells using an 
extracellularly HA-tagged version of E1 where the HA-tag was placed between the two 
N-glycosylation consensus sites (Wang and Goldstein 1995). In non-permeabilized cells,  
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Figure 2.3 Mature KCNE1 peptides do not undergo phosphorylation. Immunoblot of 
enzymatic deglycosylation of E1 N-linked glycopeptides in the presence of expressed Q1. 
The samples were left untreated (–), digested with PNGase F alone (Pf), or PNGase F and 
Calf Intestinal Phosphatase (Pf/CIP) and separated by SDS-PAGE (15%). Mature, 
immature, and unglycosylated (unglyc) samples are indicated as determined by enzymatic 
deglycosylation. Pf/CIP treatment did not result in any change in migration pattern of 
PNGase F digestion products that consistently migrated slower than immature and 
unglycosylated protein.  
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Figure 2.4 Ubiquitin modifications are absent on mature KCNE1 peptides. RIPKA-
solubilized CHO cells expressing Q1/E1 were incubated with anti-HA antibody (IP: α-
HA) to immunoprecipitate E1 protein. Samples run in duplicate and probed with anti-HA 
antibody (IB: α-HA) to visualize E1 protein or anti-ubiquitin (IB: α-Ub) to visualize 
ubiquitin attachment to E1. One-half of the total detergent solubilized lysate (1/2 Input) 
and the precipitates were analyzed by SDS-PAGE (15%).  
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no cell surface labeling of E1 was observed when E1 was expressed alone or with Q4 
(Fig. 2.5, E1 and Q4/E1 panels). Co-transfection with green fluorescent protein DNA 
verified that the absence of cell surface staining was not a result of untransfected cells. 
Permeabilization of the cells confirmed that the majority of the E1 protein was 
intracellular, as evidenced by the punctate staining pattern. In contrast, co-expression 
with Q1 resulted in striking cell surface staining of E1 in intact and permeabilized cells 
(Fig. 2.5, Q1/E1panels). 
 The plasma membrane protein levels of E1 were then quantitated by cell surface 
biotinylation. To minimize labeling of intracellular proteins and membrane recycling, 
cells expressing E1 with or without Q1 were labeled with a membrane-impermeant, 
amine-reactive biotin derivative at 4°C. When co-expressed with Q1, E1 shows robust 
cell surface expression (Fig. 2.6A). Moreover, no immature E1 was ever observed on the 
plasma membrane, which is consistent with the enzymatic deglycosylation assays (Fig. 
2.2). Little to no protein was observed at the cell surface when E1 was expressed alone. 
To account for cell rupture during biotinylation, the ER-resident protein calnexin was 
used as an internal control in all experiments. The percentage of E1 protein at the cell 
surface was quantitated as a ratio of biotinylated proteins over the total protein input 
shown in Fig. 2.6B. For Q1/E1, ~35% of E1 protein was at the cell surface after 
background subtraction. For E1 alone, the percentage of protein detected on the cell 
surface by biotinylation was within error of background calnexin labeling (4 ± 1%). 
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Figure 2.5 Cell surface expression of KCNE1 requires co-expression with K
+
 
channel subunits that assemble with KCNE peptides. Cell surface immunostaining of 
E1 expressed alone or with Q4 or Q1 in CHO cells is shown. The cells were fixed and 
left intact to visualize cell surface staining or permeabilized to visualize total cellular 
staining. The images shown are single 0.4-μm planes through the center of each cell. 
Differential interference contrast (DIC) images show both untransfected and transfected 
cells. Green fluorescent protein (GFP) images identify transfected cells. Alexa 594 
images show E1 protein staining with Alexa 594-conjugated antibodies. The fluorescent 
images were captured using the same exposure time and rendered identically to 
qualitatively compare the fluorescent intensities between panels. Note the strong cell 
surface staining for the Q1/E1 panels (non-permeabilized and permeabilized), whereas 
the E1 and Q4/E1 permeabilized panels show mostly punctate staining, indicative of 
intracellular distribution.  
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Figure 2.6 Quantification of the KCNE1 plasma membrane protein by cell surface 
biotinylation. A, a representative immunoblot of E1 expressed in CHO cells with and 
without Q1 channel subunits. Transfected cells were labeled with a membrane-
impermeant biotin reagent and subsequently lysed, and the biotinylated proteins were 
isolated from 75 μg of total protein. Lanes identified as one-fifth of the total input are 15 
μg of each sample lysate that was set aside to quantitate the total amount of biotinylated 
proteins. Biotinylated lanes are the streptavidin-bound proteins that were eluted from the 
beads and separated by SDS-PAGE (15%). The calnexin (CNX) immunoblot shows that 
the majority of the cells remained intact during the biotinylation procedure. B, 
quantification of the biotinylated E1 proteins. The percentage of biotinylated protein was 
calculated by dividing the band intensities in the biotinylated lane by the band intensities 
in the one-fifth total input lane, which were multiplied by five. There was no significant 
difference between background calnexin labeling and cell surface labeling of E1 when 
the peptide was expressed alone. Co-expression with Q1 results in 34 ± 11% E1 protein 
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on the cell surface after subtracting for background cell lysis (calnexin control).The error 
bars are standard error measurement (S.E.M.) from three immunoblots. The dotted line 
indicates background biotinylation, which was calculated from calnexin staining (4 ± 
1%).  
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 Because E1 does not reach the plasma membrane when it is expressed alone, we 
determined its intracellular localization. Results from enzymatic deglycosylation (Fig. 
2.2) narrow the spectrum of intracellular locales to the ER and/or cis-Golgi because the 
glycans on E1 were predominately immature. Initial examination of the intracellularly 
localized E1 protein by immunofluorescence afforded weak overall staining. The 
strongest signals were punctate in nature and not reminiscent of ER staining, as can be 
seen in the E1 permeabilized cells in Fig. 2.5. Accordingly, E1 did not co-stain with ER 
markers (data not shown). These observations did not correlate with the strong protein 
expression seen in Western blots (Fig. 2.1). We wondered whether antibody accessibility 
to the E1 HA tag was being prevented by lumenal proteins binding to the E1 N terminus 
because this extracellular tag is positioned between the two N-linked glycosylation 
consensus sequences (Wang and Goldstein 1995). Thus, we repositioned the HA tag to 
the intracellular C-terminus of E1. This C-terminal construct behaved similarly to the 
extracellularly tagged construct in all aspects; it assembled with Q1 channel subunits to 
afford the cardiac IKs current and required co-expression with Q1 to reach the cell surface 
with mature N-linked glycans (data not shown). In contrast to the extracellularly tagged 
E1 construct, visualization of the C-terminally HA-tagged E1 protein by 
immunofluorescence gave strong perinuclear staining (Fig. 2.7A). Counterstaining with 
calnexin and overlaying the images showed that the majority of E1 protein co-stains with 
this ER marker, although some E1 protein did not. E1 also co-stained with the cis-Golgi 
marker, β‘-COP (Palmer et al. 1993); however, the majority of the E1 protein stained in a 
pattern similar to  
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Figure 2.7 Intracellular distribution of KCNE1 peptides in CHO cells. A, co-
localization of E1 with intracellular markers. CHO cells expressing E1 alone were 
labeled for E1 along with an ER marker, calnexin (CNX), a cis-Golgi network marker 
(β‘-COP), or a trans-Golgi network marker, EYFP-Golgi (YFP-Golgi). B, co-
immunoprecipitation (IP) of E1 with anti-Q1 antibody. Digitonin-solubilized CHO cells 
expressing E1 alone (E1) or co-expressed with Q1 (Q1/E1) were incubated with (+) or 
without (–) anti-Q1 antibody. One-fifth of the total detergent solubilized lysate (1/5th 
Input) and the precipitates were analyzed by SDS-PAGE (15%).  
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calnexin. Little to no co-staining was observed when E1 was expressed with EYFP-
Golgi, which localizes to the trans-Golgi network. The intracellular staining of E1 
showed that the majority of the protein resides in the ER when it is expressed alone. We 
determined whether Q1 subunits could co-assemble with the immature glycoforms of E1 
found in the ER. Fig. 2.7B shows that all glycoforms, mature, immature, and 
unglycosylated, co-immunoprecipitate with Q1. Immunoprecipitation of E1 required co-
expression with Q1 because no bands were observed when E1 was expressed alone. 
 To verify that there are inherent differences in cellular trafficking of E1 in HEK 
cells versus CHO and COS-7 cells and not variability in experimental design, reagents, or 
constructs, we also examined E1 protein expression and trafficking in HEK cells. Unlike 
in CHO and COS-7 cells, expression of E1 in HEK cells primarily afforded the higher 
molecular mass species when it was expressed alone or with Q1 (Fig. 2.8). Treatment 
with Endo H and PNGase F confirmed that this species contained mature N-linked 
glycosylation. As we observed with CHO and COS-7 cells, PNGase F digestion of E1 
peptides from HEK cell lysates resulted in bands (indicated by the asterisks) that 
migrated slower than both immature and unglycosylated protein. Nonetheless, these 
results show that the N-linked glycans on E1 peptides in HEK cells mature without 
transiently expressed K+ channel subunits.  
 Given that E1 peptides in HEK cells exit the ER and traffic through the Golgi 
without co-expressed K+ channel subunits, we determined whether these peptides were 
reaching the plasma membrane. Using immunofluorescence, some cell surface staining  
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Figure 2.8 KCNE1 glycopeptides in HEK cells mature when expressed with or 
without K
+
 channel subunits. Shown is an immunoblot of enzymatic deglycosylation of 
E1 peptides from SDS-solubilized HEK cells transfected with E1 or Q1/E1 DNA. 
Expression of E1 with or without Q1 channel subunits results in robust expression of a 37 
kDa band that was identified as the mature N-linked glycan after enzymatic 
deglycosylation. The samples were left untreated (–), heat-treated (Δ) to 95°C for 5 min, 
digested with Endo H or PNGase F, and separated by SDS-PAGE (15%). Mature (mat), 
immature (imm), and unglycosylated (un) samples are indicated as determined by 
enzymatic deglycosylation. The asterisks (*) denote PNGase F digestion products that 
consistently migrated slower than unglycosylated or immature, which was also observed 
in CHO (Fig. 2.2) and COS-7 (data not shown).   
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was observed for E1 when expressed alone (Fig. 2.9A). However, the number of 
fluorescent cells and the intensity of cell surface staining were noticeably less than what 
was observed for Q1/E1. Quantitation of the cell surface proteins in HEK cells using 
biotinylation confirmed this qualitative observation (Fig. 2.10A). When E1 was expressed 
alone, 4 ± 2% of the protein was at the cell surface after calnexin subtraction; co-
expression with Q1 increased the E1 cell surface protein to 22 ± 3% (Fig. 2.10B).  
 The combination of weak cell surface expression and the overwhelming 
maturation of the N-linked glycans on E1 when it is expressed in HEK cells prompted us 
to examine its intracellular distribution. The C-terminally HA-tagged version of E1 was 
expressed in HEK cells and overlaid with a panel of intracellular markers (Fig. 2.9B). 
Negligible co-staining was observed with the ER marker, calnexin. Modest co-staining 
was observed with β‘-COP, but a substantial amount of E1 co-localized with EYFP-
Golgi in the trans-Golgi network. However, in all merged images, there was some 
E1protein that did not co-stain with any of the markers used. In total, these results in 
HEK cells demonstrate that the E1 protein traffics through the ER and to the Golgi 
apparatus without an exogenously expressed K+ channel. 
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Figure 2.9 Solitary KCNE1 peptides traffic to the trans-Golgi in HEK cells and 
depend on KCNQ1 K
+ channel subunits for cell surface expression. A, cell surface 
immunostaining of E1 in HEK cells. Intact cells transfected with E1 or Q1/E1 DNA were 
fixed, labeled with Alexa 594-conjugated antibodies, and visualized by wide field 
microscopy. The images shown are single 0.4-μm planes through the center of each cell. 
Differential interference contrast (DIC) panels show both transfected and nontransfected 
cells. Green fluorescent protein (GFP) panels identify transfected cells. Alexa 594 panels 
show cell surface staining of E1. B, co-localization of E1 with intracellular markers. HEK 
cells expressing E1 alone were labeled for E1 along with an ER marker, calnexin (CNX), 
a cis-Golgi network marker (β‘-COP), or a trans-Golgi network marker, EYFP-Golgi 
(YFPGolgi). Note that the calnexin/E1 panels have two cells, but only the bottom cell 
expresses E1.   
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Figure 2.10 Mature KCNE1 peptides depend on KCNQ1 K+ channel subunits for 
cell surface expression in HEK cells. A, a representative immunoblot of E1 expressed in 
HEK cells with and without Q1 channel subunits. Transfected cells were labeled as 
described for CHO cells. The calnexin (CNX) immunoblot shows that the majority of the 
cells remained intact during the biotinylation procedure. B, quantification of the 
biotinylated E1 proteins. The percentage of biotinylated protein was calculated by 
dividing the band intensities in the biotinylated lane by the band intensities in the one-
fifth total input lane, which were multiplied by five. When expressed alone, 4 ± 2% of E1 
peptides were present on the cell surface while co-expression with Q1 results in 22 ± 
11% E1 protein on the cell surface after subtracting for background cell lysis (calnexin 
control).The error bars are standard error measurement (S.E.M.) from three 
immunoblots. The dotted line indicates background biotinylation, which was calculated 
from calnexin staining (8 ± 1%).  
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DISCUSSION 
 We studied the trafficking of E1 peptides through the biosynthetic pathway by 
following the maturation of the oligosaccharides on E1 because N-linked glycan 
processing is intimately tied to cellular compartmentalization (Helenius and Aebi 2004). 
By expressing E1 alone, with Q1, or with Q4 (a K+ channel that does not assemble with 
E1), we determined that E1 glycoproteins do not mature unless they are co-expressed 
with K+ channel subunits that assemble with KCNE peptides. In addition, cell surface 
expression of E1 was also co-dependent on Q1 subunit expression, which was 
demonstrated in both qualitative and quantitative cell surface labeling experiments. 
Moreover, only the mature form of E1 was ever observed at the cell surface, indicating 
that the immature E1 protein bands observed at ~20 kDa do not correspond to E1 protein 
in functioning Q1/E1 complexes at the plasma membrane. Our results in CHO and COS-
7 cells recapitulate what has been observed in Caenorhabditis elegans where a KCNE 
homolog requires its corresponding K+ channel subunits to reach the cell surface (Bianchi 
et al. 2003).  
 The presence of immature N-linked glycans on E1 indicates that these proteins 
have yet to traffic beyond the cis-Golgi in the biosynthetic pathway and strongly suggests 
that unpartnered E1 peptides are actively prevented from trafficking past these early 
compartments in the secretory pathway. Co-localization experiments using a panel of 
intracellular markers place the majority of the E1 protein in the ER and a small fraction in 
the cis-Golgi. Although these results cannot rule out Q1/E1 complex assembly in the cis-
Golgi, the sheer abundance of unpartnered E1 peptides in the ER and co-
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immunoprecipitation of the immature and unglycosylated E1 with Q1 strongly suggest 
that Q1/E1 complex assembly occurs in the ER. An ER-based assembly for Q1/E1 
complexes directly contradicts two previous functional studies where it was proposed that 
complex assembly occurs at the plasma membrane (Romey et al. 1997; Grunnet et al. 
2002). The basis for this proposal was that Xenopus oocytes expressing unpartnered Q1 
K+ currents could be converted to KCNE-modulated currents within 24 h by a subsequent 
injection of KCNE mRNA. However, this functional change was the only evidence in 
support of this hypothesis. The cell surface and ER lifetimes of Q1 protein were not 
measured, nor was it directly shown that previously unpartnered plasma membrane Q1 
channels acquired newly synthesized KCNE peptides. The fact that the majority of the 
unassembled E1 peptides reside in the ER, possess immature N-linked glycans, and do 
not reach the cell surface in the absence of Q1 channel subunits eliminates a plasma 
membrane-based assembly mechanism for Q1/E1 complexes.  
 Enzymatic deglycosylation assays also revealed that E1 peptides potentially 
possess another post-translational modification, because we routinely observed digestion 
products that migrated slower than unglycosylated E1 (Figs. 2.2 and 2.8) in all three cell 
lines: CHO, COS-7, and HEK. These bands appeared whether the E1 peptide possessed 
one or both N-linked glycosylation sites. In addition, changing the detergent composition 
used for cell lysis or the concentration of SDS in the loading buffer did not change the 
migration or intensity of these bands. The modification may be specific to E1 because 
PNGase F treatment of KCNE3 (E3) peptides co-expressed with Q1 channels in Xenopus 
oocytes (Gage and Kobertz 2004), and CHO cells (Gage and Kobertz, unpublished 
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results) resulted in complete digestion of E3 to unglycosylated peptides. The retarded 
migration is not due to phosphorylation because treatment with phosphatase had no effect 
on the mobility of these bands (Fig. 2.3). These residual bands were also resistant to a 
subsequent neuraminidase treatment, suggesting that the removal of the sialic acids does 
not change the mobility of the E1 protein on a denaturing gel. Neuraminidase treatment 
of the N-linked glycans on Q1/E1, however, did show a subtle redistribution of the 
heterogeneous E1mature bands consistent with the removal of terminal sialic acid 
residues from N-glycans (data not shown). 
 Previous studies of E1 trafficking in HEK cells observed that wild type E1 
peptides could readily exit the ER with or without a co-expressed K+ channel 
(Krumerman et al. 2004). In light of our contrasting results using CHO and COS-7 cells, 
we re-examined the cellular processing of E1 protein in HEK cells. As was previously 
reported, E1 peptides exited the ER without the exogenous expression of K+ channels 
subunits. Using immunofluorescence, E1 protein could be detected at the plasma 
membrane in some cells; however, quantitative analysis of the cell surface population by 
biotin labeling revealed that the expression of E1 alone was barely detectable after 
background subtraction (4 ± 2%) and was considerably lower when compared with co-
expression with Q1 (22 ± 3%). Visualization of the intracellular distribution of E1 in 
HEK cells by immunofluorescence showed that the majority of the protein has trafficked 
past both the ER and cis-Golgi. Some E1 protein is localized to the trans-Golgi network; 
however, a fair amount of E1 does not co-stain with any of the secretory pathway 
markers used. The presence of E1 protein in the ER and cis- and trans-Golgi leaves open 
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the possibility that Q1/E1 complex assembly in HEK cells may not be confined to the 
early compartments of the secretory pathway. This series of experiments suggests that the 
majority of the E1 protein in HEK cells exits the ER but is trapped in the trans-Golgi or 
is trafficked to another compartment in the cell. Redistribution of E1 peptides to 
intracellular vesicles may be an ancillary mechanism that occurs in HEK cells to redirect 
unassembled, mature E1 peptides to recycling and degradation compartments.  
 These contrasting results suggest that there are inherent differences in KCNE 
trafficking in HEK versus CHO or COS-7 cells. Traditionally, the biochemical 
investigation of K+ channel α- and β-subunits has been performed in HEK cells because 
copious amounts of protein can be generated; however, these cells have been avoided for 
electrophysiological studies because endogenous voltage-gated K+ currents can be 
measured (Jiang et al. 2002). It is now known that some of these K+ channels can 
assemble with KCNE peptides, including E1 (Lewis et al. 2004). The presence of native 
K+ channels in HEK cells could explain the enigmatic trafficking of E1. In HEK cells, E1 
peptides do not reach the plasma membrane unaccompanied but assemble with 
endogenous K+ channel subunits in the secretory pathway. This inference harkens back to 
the initial discovery of E1 by expression cloning in Xenopus oocytes, where exogenously 
introduced E1 peptides assembled with endogenous Q1 channel subunits and trafficked to 
the plasma membrane producing the cardiac IKs current (Takumi et al. 1988; Folander et 
al. 1990). The low cell surface expression of E1 supports the idea that it forms complexes 
with limiting amounts of endogenous K+ channel subunits. However, the lack of 
immature E1 observed in our immunoblots suggests that protein overexpression may also 
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contribute to the artificial ER exit of E1 in HEK cells. Whether cell surface expression of 
E1 is mediated by endogenous K+ channels or by overwhelming the retention/retrieval 
machineries of the cell, studying the assembly and trafficking of KCNE peptides in HEK 
cells should be avoided. 
 The ER has two well known mechanisms for retaining misfolded and 
unassembled protein subunits: recognition of ER retention/retrieval signal sequences and 
chaperone-mediated retention of N-linked glycoproteins. The best studied ER retention 
signal to date is the RXR motif, which has been shown to regulate the ER exit of KATP 
channel subunits and sulfonylurea receptors (Zerangue et al. 1999). ER retention through 
this motif is a stringently controlled mechanism because neither protein can escape the 
ER with this signal sequence exposed. E1 peptides do not possess such a motif nor are 
they exquisitely retained in the ER when overexpressed in CHO or COS-7 cells, because 
faint bands that corresponded to mature glycoprotein were always observed with solitary 
expression of E1 (Figs. 2.1 and 2.2). Because we also observe some E1 protein in the cis-
Golgi, it is possible that E1 is subject to ER retrieval. E1 does possess a KKXX sequence, 
which is a known ER retrieval signal sequence (Ellgaard and Helenius 2003); however, 
the juxtaposition of this motif to the transmembrane domain suggests that it may function 
only as a membrane stop transfer signal (Shikano and Li 2003). It is likely that E1 
peptides are, in part, retained in the ER via their N-linked glycans through the 
calnexin/calreticulin quality control pathway, which has been shown to aid in the stability 
and ER exit of K+ channel α-subunits (Khanna et al. 2004). A calnexin/calreticulin 
association with the E1 N-terminus would also explain the lack of ER staining that we 
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observed with the extracellularly HA-tagged E1 construct, which necessitated 
repositioning of the tag. If E1 peptides are retained in the ER by calnexin or calreticulin, 
this mechanism would be applicable to all KCNE peptides because the N-linked 
consensus site closest to the N-terminus is conserved throughout the family. It is also 
feasible that multiple retention/retrieval machineries are acting on unassembled E1 
peptides or that Q1/E1 co-assembly promotes active export of the complex from the ER. 
 The goal in preventing unassembled K+ channel α- and β-subunits from leaving 
the ER is to ensure the formation of fully assembled K+ channel complexes because 
unpartnered K+ channels would have inappropriate gating and ion conducting properties. 
Although our results show that unpartnered E1 peptides reside primarily in the ER, 
homotetrameric Q1 channels have been shown to exit the ER and function at the plasma 
membrane in several different ion channel expression systems, including CHO and COS-
7 cells (Pusch et al. 1998; Tinel et al. 2000; Melman et al. 2001). In E1 knock-out mice, 
however, Q1 channels do not traffic to the apical membranes of vestibular dark cells, 
where they would normally be found with E1 in wild type cells (Nicolas et al. 2001). In 
addition, RNA interference experiments in C. elegans suggest that the stability of the K+ 
channel complex is dependent on the presence of both pore-forming and KCNE-like 
subunits (Bianchi et al. 2003). The discordant observation of unpartnered Q1 channels at 
the cell surface in expression systems may be due to Q1 channels leaking from the ER as 
a result of overexpression. Consistent with swamping the ER with overexpressed protein 
is the fact that the majority of the Q1 protein in expression systems is intracellular 
(Schroeder et al. 2000). Moreover, Q1 expressed in Xenopus oocytes or CHO cells is not 
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N-linked glycosylated (Gage and Kobertz, unpublished data) and thus not subject to 
glycosylation dependent ER retention. An alternative explanation for the ER exit of 
unpartnered Q1 channels is that E1 protein synthesis always precedes Q1 subunit 
expression in native tissues. With this temporal control, the ER is always chock full of E1 
peptides that can readily assemble with newly synthesized K+ channel subunits. This 
mechanism alleviates the need to retain unpartnered Q1 channels as long as the rate of 
co-assembly with E1 is faster than ER exit of the homotetrameric channel. There is some 
in vivo evidence in the developing ear to support this notion, because E1 protein is 
expressed in embryonic mouse vestibular dark cells 24 h before the Q1 protein (Nicolas 
et al. 2001). 
 Many studies have shown that modulation of voltage-gated K+ channels by 
KCNE peptides provides the functional diversity required for these complexes to work in 
the nervous system, muscle, colon, ear, and heart; however, for proper biological function 
these complexes must reach the plasma membrane fully assembled. Our results show that 
E1 peptides cannot advance past the cis-Golgi until they associate with Q1 channel 
subunits, which is the first step in the assembly and trafficking of KCNE-K+ channel 
complexes. Given that mutations in KCNE peptides affect the assembly and trafficking of 
the entire K+ channel complex and cause long QT syndrome, identifying the cellular 
machineries that directly ensure the proper assembly and trafficking of healthy K+ 
channel/KCNE complexes will be critical for following and interpreting the aberrant 
assembly and trafficking of diseased complexes. 
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EXPERIMENTAL PROCEDURES 
Plasmids and cDNAs—Human Q1 and E1 were subcloned into pcDNA3.1 (–) 
(Invitrogen). Two hemagglutinin A (HA)-tagged versions of E1 were used. For cell 
surface immunofluorescence experiments, an extracellular HA tag (YPYDVPDYA) was 
incorporated in the E1Nterminus between residues 22 and 23 based on the work of Wang 
and Goldstein (Wang and Goldstein 1995). For intracellular immunolocalization 
experiments, an HA tag was appended to the E1 C-terminus via a SGSG linker.  
Cell Culture and Transfections—Chinese Hamster Ovary-K1 (CHO) cells were cultured 
in F-12K nutrient mixture (Invitrogen). HEK cells and African green monkey kidney 
(COS-7) cells were cultured in Dulbecco‘s modified Eagle‘s medium (Sigma). All of the 
media were supplemented with 10% fetal bovine serum (Hyclone) and 100 units/ml 
penicillin/streptomycin (Invitrogen). For biochemical analysis, the cells were plated at 
60–75% confluency in 35-mm dishes. After 24 h, the cells were transiently transfected at 
room temperature with E1 alone, Q1/E1, or Q4/E1 at a ratio of 0.5 μg/1.5 μg with 8 μl of 
Lipofectamine (Invitrogen) for CHO cells or at a ratio of 0.25 μg/0.25 μg (COS-7 cells), 
1.25 μg/2.5 μg (HEK cells) with 10 μl of Lipofectamine 2000 (Invitrogen). Empty 
pcDNA3.1 (–) plasmid DNA (0.5 μg for CHO, 0.25 μg for COS-7, and 1.25 μg for HEK) 
was co-transfected in samples containing only E1 DNA to keep the total transfected DNA 
constant in all wells. To increase the amount of E1 protein with complex glycans in CHO 
cells, 0.75 μg of Q1 DNA was used in the co-transfection. For immunofluorescence 
studies, the cells were plated at 50% confluency onto sterile 12-mm glass coverslips 
(untreated for CHO cells, poly-D-lysine treated for HEK cells) in 24-well plates. For cell 
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surface immunofluorescence, the cells were transiently transfected with E1 alone, Q1/E1, 
or Q4/E1 by scaling down the DNA (optimized ratio for CHO cells) and lipid levels by 
one-fifth; 0.2 μg of a vector containing green fluorescent protein was co-transfected to 
serve as a transfection control. For co-localization with ER and cis-Golgi markers, 0.3 μg 
of E1 was transfected; to visualize trans-Golgi, 0.3 μg of EYFPGolgi (Clontech) was also 
transfected. Co-localization studies were performed 24 h post-transfection. For all other 
experiments, the cells were used 48 h post-transfection. 
Cell Lysis and Western Blot Analysis—The cells were washed in ice-cold PBS (3 x 2 ml) 
and lysed at 4°C in three different detergent buffers: 1% SDS lysis buffer (10 mM 
Tris·HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% SDS (w/v)), 1.5% digitonin lysis 
buffer (20 mM Tris·HCl, pH 7.4, 140 mM NaCl, 10 mM KCl, 1 mM MgCl2, 1.5% 
digitonin), and RIPKA lysis buffer (10 mM Tris·HCl, pH 7.4, 140 mM NaCl, 10 mM 
KCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate). All of the 
detergent buffers were supplemented with protease inhibitors, 1 mM 
phenylmethylsulfonyl fluoride, and 1 μg/ml each of leupeptin, pepstatin, and aprotinin. 
For expression gels, CHO cells were lysed in 300 μl of 1% SDS buffer, and COS-7 cells 
were lysed in 250 μl of RIPKA buffer. Cell debris was pelleted in a microcentrifuge 
(16,100 x g for 10 min at room temperature). The supernatants were diluted with SDS-
PAGE loading buffer containing 100 mM dithiothreitol, separated on a 15% SDS 
polyacrylamide gel, and transferred to nitrocellulose (0.2 μ; Schleicher & Schuell). The 
membranes were blocked in Western blocking buffer (5% nonfat dry milk in Tris-
buffered saline containing 0.2% Tween 20 (TBS-T)) for 30 min at room temperature and 
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then incubated with rat anti-HA (Roche Applied Science) (1:750) in Western blocking 
buffer overnight at 4°C. The membranes were washed in TBS-T (four times for 5 min) 
and incubated with goat anti-rat horseradish peroxidase-conjugated antibody (Santa Cruz 
Biotechnology, Inc.) (1:2000) in Western blocking buffer for 45 min at room 
temperature. The membranes were subsequently washed with TBS-T (four times for 5 
min). Horseradish peroxidase-bound proteins were detected by chemiluminescence using 
SuperSignal West Dura Extended Duration Substrate (Pierce) and a Fujifilm LAS-3000 
CCD camera. 
Endo H and PNGase F Deglycosylation Analysis—The cell lysates (30 μl) were diluted 
to 0.5% SDS with water and raised to 1% Nonidet P-40 (for PNGase F analysis only), 1% 
β-mercaptoethanol, 50 mM sodium citrate, pH 5.5 (for EndoH analysis) or 50 mM 
sodium phosphate, pH 7.5 (for PNGase F analysis) and then digested with Endo Hf (1 μl) 
or PNGase F (2 μl) (New England BioLabs, Inc.) for 30 min at 37°C. The samples were 
then raised to 100 mM dithiothreitol and 3.5% SDS before resolving by SDS-PAGE 
(15% gel) and analyzed by Western blot. 
KCNE1 Co-immunoprecipitation—Cells were washed in ice-cold PBS (3 x 2 ml) and 
lysed at 4 °C in 250 μl of 1.5% digitonin buffer. The cell debris was pelleted in a 
microcentrifuge (16,100 x g for 15 min at room temperature). 30 μl of cell lysate was 
incubated with 5 μl of anti-Q1 antibody (Santa Cruz Biotechnology, Inc.) for 2 h at room 
temperature. The samples were bound to protein G beads (Pierce) for 2 h at room 
temperature to separate out antibody-bound protein complexes from the cell lysate. The 
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beads were washed (three times with 500 μl) in digitonin-free wash buffer (20 mM 
Tris·HCl, pH 7.4, 140 mM NaCl, 10 mM KCl, 1 mM MgCl2. Co-immunoprecipitated 
proteins were eluted from the beads using 1x SDS-PAGE loading buffer with 200 mM 
dithiothreitol for 15 min at room temperature. One-fifth of the total input used for the co-
immunoprecipitation assay and eluted proteins were resolved by SDS-PAGE (15% gel) 
and analyzed by Western blot. 
Immunofluorescence—For visualization of intact cells, the cells were first labeled with 
rat anti-HA antibody (1:200) in culture medium for 30 min at 37°C. The cells were rinsed 
quickly in warm PBS (3 x 2 ml) before fixing in 4% paraformaldehyde (10 min at room 
temperature). The cells were then blocked in blocking solution (PBS containing 5% 
normal goat serum (Vector Laboratory, Inc.), 1% IgG-free bovine serum albumin 
(Sigma)) for 30 min at room temperature. For permeabilized samples, the cells were first 
washed in PBS (3 x 2 ml) and then fixed in 4% paraformaldehyde (10 min at room 
temperature). The cells were blocked in Triton blocking buffer (blocking solution 
containing 0.2% Triton X-100) and then incubated with rat anti-HA antibody (1:500) in 
Triton blocking buffer for 1 h at room temperature. Non-permeabilized and 
permeabilized samples were then washed with PBS (3x5 min) and incubated with goat 
anti-rat Alexa Fluor 594-conjugated antibody (Molecular Probes) (1:2000) in blocking 
solution or Triton blocking solution, respectively, for 45 min at room temperature. The 
cells were then washed with PBS (two times for 5 min; then for 1 h). The coverslips were 
dried at 37°C for 45 min before mounting on slides with ProLong® Gold Antifade 
mounting solution (Molecular Probes). For co-staining with intracellular markers, the 
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cells were fixed in 100% methanol at –20°C for 8 min, rehydrated in PBS for 5 min, and 
blocked overnight in SeaBlock Blocking buffer (Pierce). The cells were first incubated 
with rabbit anti-calnexin (Stressgen) (1:500) or concentrated mouse serum from 
monoclonal antibody CM1A10 for β‘- coatomer protein (anti-β‘COP) (Palmer et al. 
1993; Gomez et al. 2000) (1:10) in SeaBlock Blocking buffer at room temperature for 90 
min. The cells were then washed with PBS (3 x 10 min) and incubated with donkey anti-
rabbit Alexa Fluor 488-conjugated antibody (1:500) or donkey anti-mouse Alexa Fluor 
488-conjugated antibody (1:250) (Molecular Probes) in SeaBlock blocking buffer at 
room temperature for 90 min. The cells were washed in PBS (three times for 10 min) and 
labeled for E1 as described above with rat anti-HA (1:100) followed by goat anti-rat 
Alexa Fluor 594-conjugated antibody (1:500) in SeaBlock blocking buffer. After a final 
set of PBS washes (three times for 10 min), the coverslips were mounted on slides with 
Vectashield® mounting medium (Vector Laboratories). All of the cells were visualized 
using a Zeiss Axiovert 200M microscope with a 63x 1.4 N.A. oil immersion objective. z 
stacks were generated by obtaining optical sections through the samples 0.4 μm apart 
along the z axis. Deconvolution of z stack images was performed with a constrained 
iterative algorithm on Slidebook 4.0 software (Intelligent Imaging Innovations) using a 
measured point spread function. The images are displayed as single 0.4-μm planes 
through the center of each cell. 
Cell Surface Biotinylation—Cells were rinsed with ice cold PBS2+ buffer (four times with 
2 ml; PBS containing 1 mM MgCl2, 0.1 mM CaCl2) at 4°C to arrest membrane 
internalization. The cells were then incubated with 1 mg/ml sulfo-NHS-SS-biotin (Pierce) 
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in PBS2+ buffer twice for 15 min at 4°C. To quench the excess biotinylation reagent, the 
cells were washed quickly (three times with 2 ml) with quench solution (PBS2+ 
containing 100 mM glycine) and then incubated with quench solution twice for 15 min at 
4°C. The cells were lysed in RIPKA buffer for 30 min at 4°C. Cell debris was removed 
by centrifugation (16,100 x g for 10 min at 4°C). Total protein in each sample was 
quantitated by BCA analysis. Of these samples, 75 μg of total protein was separated by 
affinity chromatography on 25 μl of Immunopure® immobilized streptavidin beads 
(Pierce) overnight at 4°C, whereas 15 μg was saved as an input control to determine the 
percentage of biotinylated proteins. The beads were washed (three times with 500 μl) in 
0.1% SDS wash buffer (10 mM Tris·HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% 
SDS). Biotinylated proteins were eluted from the beads using 2xSDS-PAGE loading 
buffer with 200 mM dithiothreitol for 15 min at 55°C. The inputs and eluted proteins 
were resolved by SDS-PAGE (15% gel) and analyzed by Western blot. The images of 
nonsaturated bands were captured on a Fujifilm LAS-3000 CCD camera, and the band 
intensities were quantitated using MultiGauge V2.1 software (FujiFilm). An ER-resident 
protein, calnexin, was used as a control to determine the percentage of cell rupture that 
occurred during the labeling process. Background cell lysis was quantitated as a ratio of 
biotinylated calnexin protein to total input calnexin. The percentage of E1 protein on the 
cell surface was calculated from the ratio of avidin-bound protein to total input protein 
after background lysis subtraction.
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CHAPTER III 
POST-TRANSLATIONAL N-GLYCOSYLATION OF KCNE1 PEPTIDES: 
IMPLICATIONS FOR MEMBRANE PROTEIN ASSEMBLY IN THE ENDOPLASMIC 
RETICULUM 
 
ABSTRACT 
 N-linked glycosylation of membrane proteins is critical for their proper folding, 
co-assembly and subsequent migration through the secretory pathway.  Here we examine 
the kinetics and efficiency of N-linked glycan addition to type I transmembrane KCNE1 
K+ channel β-subunits, where mutations that prevent N-glycosylation give rise to 
disorders of the cardiac rhythm and congenital deafness.  We show that KCNE1 has two 
distinct N-linked glycosylation sites:  a traditional co-translational site and a consensus 
site ~20 residues away that unexpectedly acquires N-linked glycans after protein 
synthesis (post-translationally).  Mutations that prevent N-glycosylation at the co-
translational site concomitantly reduce post-translational glycosylation, resulting in a 
large population of unglycosylated KCNE1 peptides that do not reach the cell surface 
with their cognate K+ channel.  This long range disruption of post-translational N-glycan 
addition directly explains how a single point mutation can prevent N-glycosylation at 
multiple consensus sites, providing a new biogenic mechanism for human disease. These 
results demonstrate that post-translational N-glycosylation in the endoplasmic reticulum 
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is a cellular mechanism that ensures type I transmembrane proteins acquire the maximal 
number of glycans needed for proper complex assembly and trafficking.  
 
INTRODUCTION 
 Asparagine-linked (N-linked) glycosylation is a highly conserved protein 
modification that eukaryotic cells utilize for the proper folding, assembly and trafficking 
of membrane and secreted proteins. The initial attachment of N-linked glycans to 
polypeptides occurs in the endoplasmic reticulum (ER), where the 
oligosaccharyltransferase (OST) complex efficiently transfers a high mannose 
oligosaccharide onto asparagine residues within the primary consensus sequence N-X-
T/S-Y (sequon, where X and Y can be any natural amino acid other than proline) 
(Marshall 1972; Silberstein and Gilmore 1996). Although commonly referred to as a 
post-translational protein modification, N-linked glycosylation in mammalian cells 
typically occurs during translation as the nascent polypeptide is threaded through the 
translocation tunnel into the ER lumen (Weerapana and Imperiali 2006). Recently, 
however, one of the mammalian isoforms (STT3B) of the active site subunit of the ER 
resident OST complex has been shown to mediate post-translational N-glycosylation of a 
secreted protein, human blood coagulation factor VII (Ruiz-Canada et al. 2009). To date, 
factor VII is the only reported full-length protein that is post-translationally N-
glycosylated in mammalian cells with intact N-glycosylation machinery (Bolt et al. 
2005). Factor VII curiously contains two distinct sequons:  one sequon is modified co-
67 
 
translationally whereas the second sequon is modified post-translationally, yet the 
biological significance of a protein harboring both a co- and post-translational sequon is 
unclear. 
 Besides the structurally-distorting proline residue, three other factors can reduce 
or eliminate N-glycosylation of sequons: (1) Residues at the X-position – NXS sequons 
with negatively-charged (Asp and Glu) and hydrophobic (Trp and Leu) at the X-position 
are poorer substrates for the OST complex (Shakin-Eshleman et al. 1996; Kasturi et al. 
1997); (2) Proximity to the C-terminus – sequons within ~60 residues of the C-terminus 
often elude the OST complex, as the chain-terminated protein is believed to more rapidly 
enter the ER lumen through the translocation tunnel (Nilsson and von Heijne 2000); (3) 
Proximity to a transmembrane domain – sequons that are less than 12 residues away from 
a transmembrane segment are inaccessible to the OST active site (Nilsson and von Heijne 
1993; Cheung and Reithmeier 2007). Bioinformatic interrogation of the residues flanking 
sequons (up to 20 residues) has not identified any other sequence motifs that have long 
range effects on N-glycosylation efficiency (Gavel and von Heijne 1990; Ben-Dor et al. 
2004). 
 KCNE1 (E1) is the founding member of a family of type I transmembrane K+ 
channel β-subunits that have multiple sequons in their extracellular N-termini. E1 
peptides have two sequons at N5 and N26, both of which are obligatorily glycosylated in 
native tissues as well as in standard electrophysiological expression systems (Finley et al. 
2002; Chandrasekhar et al. 2006; Teixeira et al. 2006). E1 co-assembles with KCNQ1 
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(Q1) K+ channels to produce the slowly activating cardiac IKs current (Barhanin et al. 
1996; Sanguinetti et al. 1996) and to recycle potassium in apical membranes of strial 
marginal and vestibular dark cells in the inner ear (Wangemann 2002). A mutation that 
disrupts the sequon at N5 (T7I), gives rise to an inherited autosomal recessive form of 
Long QT Syndrome (LQTS), a disorder of the cardiac rhythm that is accompanied with 
neural deafness, Jervell and Lange-Nielsen Syndrome (JLNS) (Schulze-Bahr et al. 1997). 
A single nucleotide polymorphism in the equivalent threonine in KCNE2 (T8A) provokes 
drug-induced LQTS with the commonly prescribed antibiotic, sulfamethoxazole (Sesti et 
al. 2000; Park et al. 2003). However, the biogenic mechanism that underlies the 
importance for glycosylation at this absolutely conserved sequon remains to be 
elucidated.  
 Given the genetic linkage between N-glycosylation and KCNE biology, we 
determined the efficiency and kinetics of N-glycosylation of the two closely-spaced 
sequons in E1 and the effects of N-glycan occupancy on co-assembly with K+ channel 
subunits and cell surface expression. By comparing wild type to a panel of E1 
glycosylation mutants in metabolic labeling experiments, we found that the N-terminal 
sequon (N5) acquires its N-linked glycan during translation whereas the second glycan is 
primarily added to the internal sequon (N26) post-translationally. In contrast to wild type 
E1 peptides, mutants lacking the co-translational site are poorer substrates for post-
translational glycosylation.  Moreover, E1 subunits harboring the LQTS-associated 
mutation, T7I, exit the translocation tunnel unglycosylated where co-assembly with Q1 
inhibits post-translational glycosylation. These results provide a new biogenic mechanism 
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for channelopathies and demonstrate a need for post-translational glycosylation of 
membrane proteins in the endoplasmic reticulum.  
 
RESULTS 
N-glycan Occupancy of KCNE1 Sequons 
 The addition of N-linked glycans via the OST complex to nascent polypeptides in 
the ER translocation tunnel is conserved from yeast to humans. Accordingly, the initial 
attachment of N-linked glycans to the two N-terminal sequons in E1 is identical in a wide 
range of cells from native (cardiomyocytes and inner ear cells) to traditional expression 
systems (Xenopus oocytes, HEK-293, CHO-K1 and COS-7 mammalian cells) (Gage and 
Kobertz 2004; Chandrasekhar et al. 2006; Teixeira et al. 2006; Wu et al. 2006). To 
examine the two N-linked glycoforms of E1 individually (Fig. 3.1A), we made an initial 
panel of single glycosylation mutants that would result in glycan addition to either the N-
terminal sequon (N26Q) or the internal sequon (N5Q, T7I) and compared them to wild 
type E1 (WT). We first examined these E1 mutants without a cognate K+ channel in order 
to follow N-glycosylation without interference from co-assembly with K+ channel 
subunits. To do this, we expressed these E1 constructs in CHO-K1 cells since these cells 
lack endogenous voltage-gated K+ channel subunits that assemble with E1 peptides 
(Chandrasekhar et al. 2006). Transient expression of a C-terminal, HA-tagged WT E1 
peptide yielded two strong bands at 17 and 23 kDa on a Western blot (Fig. 3.1B, left), 
which we confirmed with enzymatic deglycosylation (Fig. 3.2) were the unglycosylated 
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Figure 3.1 Differential N-linked glycosylation of WT and mutant KCNE1 peptides. 
(A) Schematic representation of KCNE1.  The glycosylation mutants N5Q, T7I and 
N26Q are indicated by arrows.  TM, transmembrane domain.  (B) Immunoblots of WT 
and glycosylation mutant E1 peptides from solubilized CHO cells.  30 μg of total protein 
was loaded per lane. Immature and unglycosylated (unglyc) are denoted.  (C) Bar graph 
of the percentage of glycosylated WT and mutant E1 peptides.  Error bars are SEM from 
n = 3 – 6 immunoblots.   
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and immaturely N-linked glycosylated peptides, respectively (Chandrasekhar et al. 2006). 
Ablation of the N-terminal sequon (N5Q, T7I) unexpectedly prevented glycosylation of 
the internal sequon, resulting in mostly unglycosylated protein. In contrast, disruption of 
the internal sequon (N26) had no significant effect on glycosylation of the N-terminal 
sequon, though as expected, the mono-glycosylated protein migrated faster than doubly-
glycosylated WT. 
 Since there was a difference in hypoglycosylation between the hydrophilic N5Q 
and hydrophobic T7I mutants (Fig. 3.1C), we disrupted the N-terminal sequon with 
various residues to determine how mutations at the N-terminal sequon affect 
glycosylation at the internal site 20 residues away. Substitution of asparagine for 
isoleucine (N5I) reduced glycosylation at the internal site similarly to T7I (Fig. 3.1B, 
right). Mutation to residues less hydrophobic than isoleucine (T7A or T7Q) afforded 
slightly more glycosylated E1 peptide than the isoleucine mutants; however, the 
differences were not statistically significant (Table 3.1). Distorting the N-terminal sequon 
with proline (T6P) had an intermediate reduction in glycosylation, falling significantly 
between the isoleucine mutants and N5Q. This trend (T7I, N5I > T6P > N5Q > WT) 
suggests that a hydrophobic disruption of the N-terminal sequon has a long range affect 
on glycosylation of the internal site, resulting in an accumulation of unglycosylated E1 
peptides. 
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Figure 3.2 Identification of the mature, immature and unglycosylated WT and 
N26Q KCNE1 peptides. Immunoblots are from enzymatic deglycosylation of WT and 
N26Q KCNE1 peptides. The samples were left untreated (–), digested with Endo H (Hf) 
or PNGase F (Pf). (A) E1 peptides expressed alone. Endo H susceptibility of the 23 kDa 
band (WT) and the 20 kDa band (N26Q) identified these bands as immaturely 
glycosylated E1 protein, which collapsed to the ~17 kDa unglycosylated form (unglyc; 
un). (B) Q1/E1 co-expression resulted in the appearance of higher molecular weight 
bands: WT: ~40 kDa; N26Q: 25-30 kDa. Resistance to Endo H, but susceptibility to 
PNGase F identified these higher molecular weight bands as peptides with mature N-
linked glycans (m). As was previously reported (Chandrasekhar et al., 2006), exhaustive 
digestion with PNGase F results in a series of bands (denoted by asterisks) that are the 
result of an additional unidentified post-translational modification. 
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Table 3.1  Statistical Analysis of Glycosylation Mutants
1 
 WT N26Q N5Q T6P T7A T7Q N5I T7I 
WT  ns *** *** *** *** *** *** 
N26Q ns  *** *** *** *** *** *** 
N5Q *** ***  * *** *** *** *** 
T6P *** *** *  ns ns ** * 
T7A *** *** *** ns  ns ns ns 
T7Q *** *** *** ns ns  ns ns 
N5I *** *** *** ** ns ns  ns 
T7I *** *** *** * ns ns ns  
1Data are from 3 – 6 individual experiments.  Tukey‘s multiple comparison test was used 
to determine the significantly differently glycosylated mutants as ***, p < 0.0001;  **, p 
< 0.01;  *, p < 0.05 (one-way ANOVA with Tukey post-hoc analysis).  ns indicates the 
values were not significantly different from each other (p > 0.05). 
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Cellular Stabilities of WT and Mutant KCNE1 Peptides 
 To identify the cellular mechanism responsible for the large population of 
unglycosylated protein observed with the N-terminal sequon mutants (N5Q, T7I), we first 
determined whether the singly-glycosylated mutants had different protein stabilities. 
Cells expressing WT and mutant peptides were metabolically-labeled with 35S for 10 
min, chased with cold media, and the E1 peptides were isolated by immunoprecipitation 
at various time points (Fig. 3.3A). Since the zero time point is diluted with partially 
synthesized peptides (Hershey 1991), the 5 min chase point was defined as maximally-
labeled protein for the glycosylation mutants; for WT, the 10 min time point was used 
due to the delay in protein decay (Fig. 3.3B). The total protein (unglycosylated and 
glycosylated) for each time point was normalized, plotted and fitted to a single 
exponential decay (Fig. 3.3B). Surprisingly, the WT and the single site glycosylation 
mutants had experimentally similar protein stabilities (Table 3.2). Moreover, this 
similarity in protein stability did not change when we measured the decay of just the 
singly-glycosylated form of N26Q. These results show that protein stability does not 
significantly contribute to the glycosylation ratios observed with the single site 
glycosylation mutants. 
 
Co- and Post-translational N-Glycosylation of KCNE1 Peptides 
 We next determined whether the N-glycosylation rates of WT and the mutant E1 
peptides were different. To follow the rapid kinetics of N-linked glycosylation, we  
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Figure 3.3 Protein stability of WT and KCNE1 glycosylation mutants are similar. 
(A) Representative fluorographs for WT and glycosylation mutants.  S35-labeled CHO 
cells were chased for the indicated times and the E1 peptides were immunoprecipitated, 
separated by electrophoresis, and detected by autoradiography.  2-Gly: doubly 
glycosylated; 1-Gly: singly glycosylated; 0-Gly: unglycosylated.  (B) Graphs of 
densitometric analysis.  The total protein at each time point was quantified by 
densitometry, normalized to the total protein at 5 min (except WT: 10 min) and plotted 
versus chase time.  WT: closed circles; N5Q: gray triangles; T7I: open triangles; N26Q: 
gray squares are mean ± SEM (n = 3 – 4) for each chase point for WT, N5Q, T7I and 
N26Q respectively.  Data were fitted to a single exponential and rate of decay values are 
tabulated in Table 3.2.   
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Table 3.2 Protein decay and post-translational glycosylation rates of KCNE1 
peptides
1
 
 
KCNE1 peptide 
 
 
Rate of decay (min) 
 
 
Post-translational glycosylation (min) 
 
WT 33 ± 4 ns 8.5 ± 2.0 ns 
N5Q 33 ± 5 ns 15 ± 5 
T7I 46 ± 3 ns 20 ± 4 
N26Q 38 ± 2 ns ND 
N26Q (1-gly) 37 ± 3 ns NA 
1Data are from 3 – 5 individual experiments.  Data were fitted to a single exponential.  
Values are mean ± SEM.  ns indicates that the rates were not significantly different 
from each other (one-way ANOVA with Tukey post-hoc analysis (p > 0.05))   ND, 
not detectable; NA, not applicable. 
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metabolically-labeled cells using 2 min pulses. This shorter pulse allowed us to 
differentiate between co- and post-translational N-linked glycosylation since the 
translation of all of the E1 polypeptides initiated during the pulse will be completed by 
the 5 min chase (Hershey 1991). Figure 3.4A shows a time course for WT and mutant E1 
peptides. At each chase time point, the different glycosylation states were plotted as a 
percentage of the total protein (Fig. 3.4B). For WT, the doubly-glycosylated form of the 
protein steadily increased whereas the singly- and unglycosylated forms decreased over 
the duration of the 20 min time course. The increase in doubly-glycosylated E1 after the 5 
min chase indicates that N-linked glycans were attached after protein translation. 
Therefore, we used the E1 mutants to determine which N-linked glycosylation site(s) 
were responsible for the slower, post-translational glycosylation of WT. For N26Q, the 
singly glycosylated form of the protein was abundant within the first 5 minutes, 
consistent with N-linked glycan addition to the N-terminal sequon during translation. 
Conversely, N5Q and T7I were poorly glycosylated during the protein translation time 
window, resulting in predominantly unglycosylated protein. However for both N5Q and 
T7I, the singly glycosylated form exponentially increased over 5 – 20 min whereas the 
glycosylation state of N26Q remained constant after 5 min (Fig. 3.4B, Table 3.2). This 
kinetic difference in N-linked glycan addition identified the internal glycosylation site as 
a source of the post-translational glycosylation observed with WT. These results 
demonstrate that the glycosylation timing and efficiency at the two sequons on E1 are 
different: N-linked glycans are readily added to the N-terminal sequon during translation 
whereas glycosylation of the internal site is delayed and less efficient.  
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Figure 3.4  KCNE1 peptides are co- and post-translationally N-glycosylated. (A, C) 
CHO cells were pulsed for 2 min, chased for the indicated times and the E1 peptides were 
immunoprecipitated, separated by electrophoresis, and detected by autoradiography.  
Representative fluorographs for WT and E1 mutants expressed alone (A) and with Q1 
channel subunits (C).  (B) Graphs of densitometric analysis for Fig. 3.4A.  The 
percentage of the different glycoforms with respect to total protein is plotted for each 
time point.  After 5 min, the fully glycosylated forms of WT, N5Q and T7I increased 
whereas N26Q remained constant.  The increase in glycosylation was fitted to a single 
exponential and tabulated in Table 3.2.  N26Q is a linear fit for comparison purposes.  
Data (n = 3 – 5) are mean ± SEM for each chase point.  (D) Graphs of densitometric 
analysis for Fig. 3.4C.  The percentage of the maximally glycosylated form of WT (two) 
and the E1 mutants (one) with respect to total protein is plotted for each time point.  The 
fits from Fig. 3.4B were scaled to compare the post-translational glycosylation rates in 
the presence of Q1 channel subunits (solid lines).  Data (n = 3 – 5) are mean ± SEM for 
each chase point.  Glycosylation states in all panels are labeled:  2-Gly: open square; 1-
Gly: closed square; 0-Gly: open circle.   
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 Since KCNE peptides are regulatory subunits that co-assemble with K+ channel 
subunits in the ER (Krumerman et al. 2004; Chandrasekhar et al. 2006), we next 
determined whether the presence of K+ conducting subunits affected the post-
translational glycosylation of E1 peptides. Cells co-expressing Q1 channel subunits with 
WT and mutant E1 peptides were pulsed for 2 min and chased at different times to 
observe post-translational glycosylation (Fig. 3.4C). Although co-expression with Q1 
channel subunits eventually leads to N-glycan maturation in the Golgi complex (vide 
infra), the chase time points needed to detect post-translational glycosylation are too 
short to observe mature glycosylated E1. Thus, in these experiments, the immature form 
of E1 is predicted to be the end glycoform as shown in Figure 3.4C. The maximally-
glycosylated form of the E1 peptides in the presence of Q1 was calculated from the pulse 
chase data in Figure 3.4C, plotted in Figure 3.4D, and compared to post-translational 
glycosylation of solitary E1 peptides by re-plotting the curves from Figure 3.4B (solid 
lines). Co-expression with Q1 reduced the overall glycosylation efficiency of the E1 
peptides; however, the rate of post-translational glycosylation of WT and N5Q was 
unaffected. As expected, the glycosylation of N26Q was also relatively unaffected by Q1 
co-expression since this mutant primarily acquires its N-glycans during translation. In 
striking contrast, post-translational glycosylation of T7I was strongly inhibited, 
suggesting that co-assembly with Q1 channel subunits prevents the OST complex from 
attaching an N-linked glycan to the T7I internal sequon. 
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Consequences of KCNE1 Hypoglycosylation 
 We subsequently determined whether the compounded hypoglycosylation of the 
E1 mutants altered their ability to traffic to the cell surface with Q1 subunits. Given the 
contrasting differences in the current profiles between unpartnered Q1 channels and 
Q1/E1 complexes (Fig. 3.5A), we initially used electrophysiology to measure the 
function of WT and mutant Q1/E1 complexes. Unpartnered Q1 channels give rise to 
small currents that rapidly activate as well as inactivate with depolarization. In contrast, 
Q1/E1 complexes have larger currents that slowly activate over many seconds and show 
no measurable signs of inactivation. Thus, co-assembly with E1 bestows the Q1 channel 
with the appropriate properties to maintain the rhythmicity of the heartbeat and provide 
salt and water transport in the inner ear. Co-expression of Q1 with the glycosylation 
mutants afforded currents that were an amalgam of unpartnered Q1 channels (Fig. 3.5B, 
arrowheads) and Q1/E1 complexes. Since the amount of unpartnered Q1 currents varied 
from cell to cell for each individual mutant, we measured the currents from several cells 
and normalized current activity relationships for the E1 mutants to WT (Fig. 3.5C). The 
systematic decrease in maximal current of the glycosylation mutants followed the 
hypoglycosylation trend (Fig. 3.1C), consistent with fewer Q1/E1 complexes functioning 
at the cell surface. 
 To directly measure the plasma membrane expression of the mutant E1 peptides 
co-expressed with Q1 channel subunits, we used cell surface biotinylation.  This 
biochemical approach also allowed for the identification of the E1 glycoforms present on 
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Figure 3.5 Current properties of KCNQ1 channels co-expressed with KCNE1 
glycosylation mutants.  (A) Representative families of IQ1 and IKs currents recorded by 
perforated patch clamp from CHO cells using the following voltage protocol: the currents 
were evoked by 3-s depolarization pulses from a holding potential of -80 mV to test 
voltages –70 to +60 mV in 10-mV increments at an interpulse interval of 30 s.  The 
depolarization pulses were followed by repolarization to –30 mV for 2 s to monitor tail 
currents.  Cells were transfected with a KCNQ1 plasmid only (KCNQ1) or cotransfected 
with WT KCNE1 (+E1).  (B) Representative families of currents recorded from cells 
expressing KCNQ1 and the KCNE1 mutants (+N5Q, +T7I or +N26Q).  Arrowheads 
indicate current from unpartnered Q1 channels. (C) Relative mean peak currents (I/Imax) 
were normalized to the maximal WT Iks (+E1) and plotted as a function of the pulse 
voltage (V).  Data (n = 3 – 5) are mean ± SEM. 
86 
 
 the plasma membrane. Cells expressing WT and mutant Q1/E1 complexes were labeled 
with a membrane impermeant, amine-reactive biotin reagent at 4˚C to prevent membrane 
recycling and minimize labeling of intracellular proteins. The biotinylated proteins were 
isolated with streptavidin beads (Beads) and normalized to their respective endogenous 
calnexin (CNX) signal (½ Input) to compare the cell surface expression of WT to the E1 
mutants (Fig. 3.6). To verify that the cells remained intact during biotinylation, we also 
monitored the labeling of an ER-resident protein, calnexin – CNX (Beads), and 
subtracted out this background intracellular labeling to calculate the normalized cell 
surface expression in Figure 3.6B. E1 peptides with a single glycan attached to the N-
terminal sequon (N26Q) had cell surface expression that was similar to WT (Fig. 3.6) and 
was dependent on co-expression with Q1 (Fig 3.7). In contrast, E1 mutants lacking the N-
terminal sequon (N5Q, T7I) were challenging to detect at the plasma membrane even 
when they were co-expressed with Q1.   
 We next used enzymatic deglycosylation to determine which glycoforms of the 
mutants were present at the plasma membrane. As we have previously shown with WT 
Q1/E1 complexes, E1 peptides are post-translationally modified in the Golgi, resulting in 
a strong, but diffuse band centered between 37 and 50 kDa, which is due in part to the 
maturation of the N-linked glycans (Chandrasekhar et al. 2006). Using deglycosylation 
enzymes (Fig. 3.2B), we identified the unglycosylated, immaturely and maturely N-
glycosylated forms of WT and mutant E1 peptides, which are denoted in Figure 3.6A. 
Although all three glycoforms of WT and the E1 mutants were present in the cells (Fig. 
3.6A, ½ Inputs), only maturely N-glycosylated protein was detected at the cell surface 
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Figure 3.6 Mature KCNE1 glycopeptides reach the plasma membrane. (A) 
Representative immunoblots of WT and the glycosylation mutants co-expressed with 
KCNQ1.  Transfected CHO cells were labeled with a membrane impermeable biotin 
reagent, lysed, and the biotinylated proteins were isolated with streptavidin beads.  Lanes 
denoted as (½ input) are half the sample lysate that was set aside to quantitate the total 
amount of biotinylated proteins.  (Beads) lanes represent the streptavidin-bound proteins 
that were isolated and separated by SDS-PAGE.  The calnexin (CNX) immunoblots were 
used both to determine the amount of background lysis and to compare the cell surface 
expression of the mutants to WT.  The mature (m), immature (im) and unglycosylated 
(un) forms of the E1 glycopeptides were identified by enzymatic deglycosylation (Fig. 
3.2).  (B) Quantification of the biotinylated E1 proteins on the cell surface.  Band 
intensities for biotinylated E1 proteins were calculated as described in the Experimental 
Procedures and normalized to input calnexin for the corresponding data set.  The error 
bars are SEM from n = 3 – 4 immunoblots.   
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Figure 3.7 Cell surface expression of WT and mutant KCNE1 peptides requires 
KCNQ1 channels. (A) Representative immunoblots of WT and the glycosylation 
mutants. Transfected CHO cells were labeled with a membrane impermeable biotin 
reagent, lysed, and the biotinylated proteins were isolated with streptavidin beads. Lanes 
denoted as (½ input) are half of the sample lysate that was set aside to quantitate the total 
amount of biotinylated proteins. (Beads) lanes represent the streptavidin-bound proteins 
that were isolated and separated by SDS-PAGE. The calnexin (CNX) immunoblots were 
used to determine the amount of background lysis. The mature (m), immature (im) and 
unglycosylated (un) forms of the E1 glycopeptides were identified by enzymatic 
deglycosylation (Fig 3.2). (B) Quantification of the biotinylated E1 proteins on the cell 
surface. To obtain the percentage of E1 protein on the cell surface, the percentage of 
CNX labeling was subtracted from the percentage of biotinylated E1 protein, which was 
determined by dividing the band intensities in the beads lane by twice the band intensity 
in the corresponding half input lanes. Statistically, there was no cell surface expression of 
E1 peptides when expressed alone: WT: 2.3 ± 3%; N5Q: 0.5 ± 2.2; T7I: 0.3 ± 1.9; N26Q 
0.5 ± 0.2 (open bars). Cell surface expression of WT E1 protein co-expressed with Q1 is 
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shown for comparison (Q1/E1: filled bar) where 20 ± 3% of the E1 protein is on the cell 
surface. The error bars are SEM from n = 3-4 immunoblots.   
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over background calnexin labeling. Moreover, the abundance of intracellular, 
unglycosylated T7I peptides in the presence of Q1 channel subunits is consistent with the 
inhibition of post-translational glycosylation of T7I in Figure 3.4D. In total, these results 
demonstrate that cell surface expression of E1 peptides requires the acquisition of at least 
one N-linked glycan to reach the plasma membrane. Thus, mutations that directly prevent 
co- and reduce post-translational N-glycosylation result in a large population of 
unglycosylated E1 peptides, which severely reduces the number of functional Q1/E1 
channel complexes at the cell surface. 
 
DISCUSSION 
 Motivated by the genetic evidence that the N-terminal sequon in KCNE peptides 
plays an important role in cardiac biology (Schulze-Bahr et al. 1997; Sesti et al. 2000; 
Park et al. 2003), we individually examined the kinetics and extent of N-linked 
glycosylation of the two E1 sequons. The results from our investigation provide four 
mechanistic insights into the biogenesis and N-glycosylation of these type I 
transmembrane peptides: (1) The two N-linked consensus sites on E1 are handled 
differently in the ER: glycans are added to the N-terminal sequon during translation 
whereas the glycans are predominately attached to the internal site after translation has 
been completed. (2) Post-translational glycosylation of E1 peptides lacking a co-
translational site is less efficient, compounding hypoglycosylation and resulting in a 
majority of unglycosylated peptides. (3) Co-assembly with Q1 channel subunits 
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additionally inhibits post-translational glycosylation of some mutant E1 peptides. (4) 
Unglycosylated E1 peptides do not reach the cell surface with or without Q1 K+ channels. 
Thus, mutations that inhibit co-translational N-glycosylation reduce the population of 
functioning Q1/E1 complexes at the cell surface, providing a biogenic mechanism for 
Long QT and Jervell and Lange-Nielsen Syndromes.   
 
Post-translational Glycosylation of Properly Folded KCNE subunits 
 Post-translational glycosylation has been historically associated with cells with 
compromised N-glycosylation machinery (Duvet et al. 2002) or that express truncated 
glycoproteins (Kolhekar et al. 1998). All E1 constructs used here are full-length. 
Moreover, post-translational glycosylation affords the predominant glycoform of E1 – the 
doubly glycosylated form – which assembles with Q1 subunits to afford K+ channel 
complexes that generate the hallmark cardiac IKs current (Fig. 3.5). Similarly, post-
translational glycosylation of E1 is neither a cell-specific artifact nor a result of depleting 
the key components of the N-glycosylation pathway. Post-translational glycosylation of 
E1 was observed in several standard mammalian cell lines (Fig. 3.8A), consistent with 
the conservation of the STT3B subunit, which has been recently shown to attach N-
glycans to secreted proteins after translation (Ruiz-Canada et al. 2009). Although 
exogenous expression of E1 was needed to generate a detectable protein signal, it did not 
saturate the co-translational machineries or deplete the dolichol-linked oligosaccharides 
since co-translational glycosylation of endogenous cathepsin C was unaffected (Fig.  
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Figure 3.8 Post-translational N-glycosylation of exogenously expressed KCNE1 
peptides occurs in various cell types with fully functional co-translational 
machinery. (A) Cells were pulsed for 2 min, chased for the indicated times and the E1 
peptides were immunoprecipitated, separated by electrophoresis, and detected by 
autoradiography. Representative fluorograph for WT E1 expressed in CHO cells is shown 
for comparison. (B) Graphs of densitometric analysis for Figure 3.8A. The percentage of 
the different glycoforms with respect to total protein is plotted for each time point. After 
5 min, the fully glycosylated forms of WT protein increased in all mammalian cell lines. 
Glycosylation states in all panels are labeled: 2-Gly: open square; 1-Gly: closed square; 
0-Gly: open circle. (C) Representative fluorograph for human cathepsin C. HeLa cells 
transfected with empty vector (pcDNA3.1), WT or T7I were pulsed for 2 min and chased 
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for the indicated times. Endogenous cathepsin C was immunoprecipitated, separated by 
electrophoresis and detected by autoradiography. Only the fully glycosylated protein (4-
Gly) was observed at 0 and 10 min chase points, demonstrating that plasmid-based 
expression of E1 peptides does not compromise the co-translational N-glycosylation 
machinery. Endo H (Hf) was used to identify unglycosylated cathepsin C (0-Gly).  
95 
 
3.8C). Taken together, these results suggest that post-translational glycosylation of E1 is 
a native mechanism that affords assembly-competent regulatory subunits essential for 
proper electrical excitability.  
 
Proteins with Distinct Co- and Post-translational Sites 
 For a type I transmembrane peptide with closely-spaced N-linked consensus sites, 
the cellular mechanisms that define its co- and post-translational glycosylation sequons 
are likely to be different. One possible explanation for distinct co- and post-translational 
sequons is that the E1 N-terminus is oriented in the ER translocation tunnel such that the 
OST complex has access to only the N-terminal sequon. Similarly, the internal sequon 
could simply be occluded by the translocation tunnel. Previous investigations have 
utilized the ―rule of 14‖ for membrane proteins:  N-linked consensus sequences need to 
be at least 12-14 residues away from a transmembrane domain to be a substrate for the 
OST complex (Nilsson and von Heijne 1993; Cheung and Reithmeier 2007). However, 
the E1 internal sequon satisfies this rule, as it is 18 residues away from the predicted start 
of the transmembrane segment. Moreover, the E1 internal sequon is glycosylated, it just 
occurs after translation. Our results suggest the ER proteins responsible for post-
translational glycosylation have a different set of structural requirements that define 
which consensus sites are acceptable substrates.    
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Post-Translational versus Post-Translocational N-glycosylation 
 We have shown that the internal sequon of E1 acquires N-linked glycans after 
translation, but do these modifications occur outside of the protein translocation tunnel? 
Although we cannot rule out the possibility that some glycans are post-translationally 
added when the fully-synthesized peptide resides in the translocation tunnel, two 
experimental observations support a mechanism where post-translational glycosylation 
occurs after the transmembrane segment slides into the hydrophobic confines of the 
membrane. Currently, there are two models for the timing of the lateral entry of a 
transmembrane segment into the ER membrane based on photo-crosslinking studies. The 
first model requires the completion of translation before exiting the translocation pore 
(Do et al. 1996) whereas the second model suggests that certain transmembrane segments 
can enter the lipid environment before translation is terminated (Heinrich et al. 2000; 
McCormick et al. 2003). Thus, the observation of N-glycosylation events 10 – 15 minutes 
after translation of a ~150 residue type I transmembrane peptide (Fig. 3.4B) is consistent 
with post-translocational glycosylation.  Moreover, post-translational glycosylation of the 
T7I mutant was inhibited by co-expressing Q1 channel subunits (Fig. 3.4D) that co-
assemble with E1 peptides in the ER (Krumerman et al. 2004; Chandrasekhar et al. 
2006). Since the protein translocation tunnel cannot simultaneously house a six-
transmembrane spanning Q1 subunit and an E1 peptide, these data support the conclusion 
that post-translational glycosylation of type I transmembrane peptides occurs outside of 
the protein translocation tunnel.  
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Efficiency of Post-Translational N-glycosylation of Type I Transmembrane Peptides 
 The panel of E1 mutants that we examined revealed some basic structural 
requirements for post-translational glycosylation of type I transmembrane peptides. First, 
unlike co-translational glycosylation, long range point mutations (~20 residues away) 
affect post-translational glycosylation, as ablation of the N-terminal sequon with more 
hydrophobic residues led to less post-translational glycosylation (Fig. 3.1C). This trend is 
consistent with the best substrate for post-translational glycosylation, wild type E1, which 
is decorated with hydrophilic carbohydrates at its N-terminal sequon. Interestingly, we 
could not detect any post-translational glycosylation of the N26Q mutant, which suggests 
that the N-terminal sequon is a poor substrate for post-translational glycosylation. This 
phenomenon has been previously observed with water soluble proteins where rapid 
protein folding sequesters the sequon from the OST complex (Ruiz-Canada et al. 2009). 
However, the N-terminus of E1 is not predicted to have a globular fold nor does it 
possess any lumenal cysteines for disulfide bond formation. While we could not directly 
measure post-translational glycosylation of N26Q (Fig. 3.4B), the steady state 
populations (0 and 2 glycans) of WT peptides suggest that the N-terminal sequon 
acquires N-linked glycans post-translationally when the internal sequon is glycosylated. 
Differences in the degradation rates of the differently glycosylated WT peptides could 
also explain the lack of the singly glycosylated species; however, the degradation rates of 
WT and mutant E1 peptides were comparable in the absence of Q1 channel subunits (Fig. 
3.3). Nonetheless, these data hint that glycan occupancy directly affects post-translational 
glycosylation efficiency of type I transmembrane peptides.  
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Cellular Advantages of Doubly-Glycosylated Type I Transmembrane Peptides 
 The spacing of the N-linked glycosylation consensus sites in E1 is absolutely 
conserved among vertebrates. Moreover, 4 out of the 5 human KCNE peptides have at 
least two N-linked sites and the spacing between the sequons is relatively consistent (16 – 
23 aa). A potential benefit of having two sequons is to increase the probability that 
KCNE peptides are at least singly glycosylated in the ER. KCNE peptides with only an 
N-terminal sequon would likely mimic the N26Q mutant, which is not a substrate for 
post-translational glycosylation (Fig. 3.4B). Another potential advantage of a doubly-
glycosylated KCNE peptide is that it would improve the interactions (via multivalency) 
with the lectin family of chaperones in the ER (Helenius and Aebi 2001), which have 
been hypothesized to interact with E1 (Chandrasekhar et al. 2006). The initial delay in the 
decay of WT peptides that we observed is consistent with the notion that there is an 
increase in the probability of lectin chaperone association with newly synthesized E1 
peptides harboring two glycans (Fig. 3.3B).  
 
Biogenic Model for Long QT Syndrome 
 From our results, we propose a model for E1 peptide biogenesis, co-assembly 
with Q1 channel subunits, and the implications for Long QT and Jervell-Lange Nielsen 
Syndromes (Fig. 3.9). In this model, WT peptides co-translationally acquire an N-
terminal glycan before exiting the translocon. Once free from the proteinaceous 
environment of the translocon, post-translational glycosylation of E1 peptides occurs  
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Figure 3.9 Model of KCNE1 biogenesis, N-glycosylation and co-assembly with 
KCNQ1 channels.  N-linked glycans are added to the N-terminal sequon (N5) of E1 
peptides during translation (Co-translational) and laterally exit the translocon into the 
membrane. Post-translational glycosylation of WT peptides at N26 occurs either before 
(a) or after (b) co-assembly with Q1 channel subunits.  Once fully glycosylated, the 
Q1/E1 complex exits the ER and traffics to the plasma membrane.  For the Long QT 
mutation, T7I, post-translational glycosylation is inhibited by co-assembly with Q1 
channel subunits resulting in Q1/E1 complexes that do not reside at the plasma 
membrane.  
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either before or after co-assembly with Q1 channel subunits (pathways a and b, 
respectively). Once fully glycosylated, Q1/E1 complexes exit the ER and traffic to the 
plasma membrane. For WT peptides, we cannot rule out either pathway a or b since co-
expression with Q1 channel subunits had no significant effect on post-translational 
glycosylation. In contrast, post-translational glycosylation of T7I was inhibited by Q1 co-
expression, which shunts the unglycosylated peptides towards co-assembly, resulting in a 
pool of unglycosylated Q1/T7I complexes that do not reside at the plasma membrane 
(Fig. 3.9, T7I) as evidenced by the lack of cell surface expression of these channel 
complexes (Fig. 3.6). Therefore, the lack of N-linked glycosylated E1 peptides in the 
heart would decrease the number of Q1/E1 complexes at the cell surface, leading to a 
reduction in the cardiac IKs current and a prolongation of the QT interval. Alternatively, a 
smaller population of assembly-competent E1 peptides could result in either unpartnered 
Q1 channels trafficking to the cell surface (as we observed in Fig. 3.5B) or assembly with 
different KCNE peptides since the mRNA for all five KCNE peptides is expressed in 
heart tissues (Bendahhou et al. 2005; Lundquist et al. 2005). Either scenario would result 
in ill-equipped Q1 channels, which would increase the probability of an arrhythmic event. 
A similar reduction of Q1/E1 complexes in the developing ear would prevent the proper 
potassium flux into and thus the formation of the endolymphatic space. Given the 
absolute conservation of the N-terminal site in KCNE peptides, we predict that mutations 
that prevent N-linked glycosylation in other members of the KCNE family will also 
compromise K+ channel complex assembly and give rise to channelopathies.   
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EXPERIMENTAL PROCEDURES 
Plasmids and cDNAs—Human Q1 and E1 were subcloned into pcDNA3.1 (–) 
(Invitrogen).  E1 constructs (wild type and mutants) possessed a C-terminal HA 
(YPYDVPDYA) epitope tag (Chandrasekhar et al. 2006). To produce the N5Q, N5I, 
T6P, T7I, T7A, T7Q and N26Q mutants, site-directed mutagenesis was performed using 
QuikChange® (Stratagene) and the mutations were confirmed by DNA sequencing of the 
entire gene.   
Cell culture and transfections—Chinese Hamster Ovary (CHO-K1) cells were cultured in 
F-12K nutrient mixture (Gibco – Invitrogen). HeLa cells and HEK cells were cultured in 
Dulbecco's modified Eagle's medium (Sigma). All of the media were supplemented with 
10% fetal bovine serum (Hyclone) and 102 U/mL penicillin/streptomycin (Gibco – 
Invitrogen). Cells were plated at 60 – 75% confluency in 35 mm dishes for all 
experiments except pulse-chase (60 mm). After 24 h, cells were transiently transfected at 
RT with Lipofectamine (Invitrogen) 8 μl per mL of Opti-MEMI (Gibco - Invitrogen) for 
CHO cells or with 10 μl of Lipofectamine 2000 (Invitrogen) per mL of Opti-MEM for 
HeLa cells and HEK cells and returned to fresh media after 6 hr (2 hr for 
electrophysiology). DNA ratios (in μg):  E1/empty pcDNA 3.1 plasmid: 1.25/1.25; 
Q1/E1 (Western Blots): 1.25/1.25; Q1/E1 (Pulse-chase): 0.75/1.75; Q1/E1 + pEGFP-C3 
(electrophysiology): 0.5/2 + 0.25. Cells were used 48 h post-transfection for Western 
Blots; 24 h for pulse-chase and electrophysiological experiments. 
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Cell lysis and Western Blot Analysis—Cells were washed in ice-cold PBS (3 × 2 mL) and 
lysed at 4°C in RIPKA buffer (in mM):  10 Tris·HCl, pH 7.4, 140 NaCl, 10 KCl, 1 
EDTA, and 1% Triton-X, 0.1% SDS, 1% sodium deoxycholate and supplemented with 
protease-inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 µg/mL each of 
leupeptin, pepstatin and aprotinin (LPA). Lysates were diluted with SDS-PAGE loading 
buffer containing 100 mM DTT, loaded on a 15% SDS-polyacrylamide gel, transferred to 
a nitrocellulose membrane, and blocked in Western blocking buffer (5% nonfat dry milk 
in Tris-buffered saline containing 0.2% Tween-20 (TBS-T)) for 30 min at RT. 
Membranes were incubated overnight at 4°C with rat anti-HA (Roche) (1:750) in 
Western blocking buffer and washed in TBS-T next day and incubated with goat anti-rat 
horseradish peroxidase (HRP)-conjugated antibody (Jackson Immunoresearch Labs, Inc.) 
(1:2000) in Western blocking buffer for 45 min at RT. Membranes were washed with 
TBS-T and incubated with SuperSignal West Dura Extended Duration Substrate (Pierce) 
for 5min.  HRP-bound proteins were detected by chemiluminescence using Fujifilm 
LAS-3000 CCD camera and quantified using the Image Gauge V2.1 software (Fujifilm).   
Enzymatic deglycosylation assay—NP-40, BME, and reaction buffer (G5 for Endo H; G7 
for PNGase F) were added to the cell lysates (20 µL), which were diluted with water such 
that the final concentrations were 1% for NP40 and BME.  Endo Hf (2 µL) or PNGase F 
(1 µL) (New England BioLabs, Inc.) were added to the samples and incubated at 37°C for 
30 min.  The samples were brought to a final concentration of 100 mM DTT and 1.3% 
SDS and separated on an SDS-PAGE (15% gel) and analyzed by Western Blot as 
described above.   
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Cell surface biotinylation—Transfected cells were rinsed with ice-cold PBS2+ buffer 
(PBS containing 1 mM MgCl2, 0.1 mM CaCl2), incubated with 1 mg/mL sulfo-NHS-SS-
biotin (Pierce) in PBS2+ buffer for 2 × 15 min at 4°C. The biotin reagent was quenched by 
washing with (3 × 2 mL) with quench solution (PBS2+ containing 100 mM glycine) and 
then incubated with quench solution for 2 × 15 min at 4°C. Cells were lysed in RIPKA 
buffer and cell debris was removed by centrifugation. For each sample, 75 µg of total 
protein was quantitated by BCA analysis and incubated with 25 µL of Immunopure® 
Immobilized streptavidin beads (Pierce) overnight at 4°C. One-half of the input (37.5 µg 
of total protein) was saved as a control for each sample. Beads were washed 3 times with 
0.1% SDS buffer (500 µL) and biotinylated proteins were eluted first with 30 µl 2× SDS-
PAGE and 200 µM DTT mix for 15 min at 55°C, then with 30 µl 200 µM DTT for 5 min 
at 55°C and the two elutions were combined to achieve 60 µl final volume. Half of the 
input and bead-eluted proteins were separated by SDS-PAGE, analyzed by Western Blot 
as described above, and quantified in the linear range. To compare the cell surface 
populations of WT to the mutant E1 peptides, the band intensities in the beads lanes were 
divided by twice the band intensity in the corresponding calnexin ½ input lanes and WT 
was normalized to 1. Since some cell lysis and intracellular labeling of proteins occurs 
during biotinylation, the amount of calnexin (CNX) labeling was first subtracted from 
each biotinylated E1 sample. 
Pulse-chase experiments—Cells were washed in PBS (2 × 2 mL) and starved in 
Dulbecco‘s modified Eagle medium (DMEM) High Glucose (Gibco - Invitrogen) 
supplemented with 10% fetal bovine serum (Hyclone) and 102 U/mL 
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penicillin/streptomycin (Gibco – Invitrogen) and 2 mM glutamine (Invitrogen) for 1 h at 
37°C. Then, 100 μCi/mL [35S] methionine and [35S] cysteine (MP Biomedicals, Inc.) was 
added to the starve media and the cells were pulsed 10 min for decay experiments and 2 
min for post-translational glycosylation studies. After the radioactive pulse, cells were 
washed in PBS (2 × 2 mL) and chased in standard medium at various times. The cells 
were washed in PBS (2 × 2 mL) and lysed for 30 min at 4°C in 300 µL low salt lysis 
buffer consisting of (in mM): 50 Tris·HCl, pH 7.4, 150 NaCl, 20 NaF, 10 Na3VO4, and 
1% NP-40, 1% CHAPS supplemented with protease-inhibitors (PMSF and LPA).   
Radioimmunoprecipitation assay—Lysates were pelleted at 16,100 g for 10 min at RT 
and supernatant was precleared with a slurry of Immobilized Protein G Beads (Pierce) in 
lysis buffer rotating for 2 h at 4°C. The beads were pelleted and the precleared 
supernatants were rotated overnight at 4°C with 25 µl Protein G Beads/(1 µl) rat anti-HA 
(Roche) antibody mix or with 25 µl Protein G Beads/(1 µl) goat anti-human cathepsin C 
(R&D Systems) antibody mix. The beads were pelleted at 16,100 g for 10 min at RT and 
washed twice in low salt lysis buffer and then twice in high salt buffer consisting of (in 
mM):  50 Tris·HCl, pH 7.4, 500 NaCl, 20 NaF, 10 Na3VO4, and 1% NP-40, 1% CHAPS, 
followed by a final wash with low salt lysis buffer. For cathepsin C enzymatic 
deglycosylation assay, beads were resuspended in 400 µl low salt lysis buffer with Endo 
Hf (20 µL) (New England BioLabs, Inc.) and incubated at 37°C for 1 h followed by a 
final wash with low salt lysis buffer. The washed and pelleted beads were eluted in 50 µL 
of 2 X SDS and 100 mM DTT mix at 55oC for 15 min. Supernatants were separated by 
SDS-PAGE (15%) and visualized by autoradiography. Signals were captured on a FLA-
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3000 phosphorimager and quantified using the Image Gauge V2.1 software (Fujifilm). 
The rates of protein decay and post-translational glycosylation were fitted to a single 
exponential.   
Perforated Patch Whole-Cell Recordings—IQ1 and IKs were recorded in the whole-cell 
perforated patch configuration. Briefly, on the day of the experiment, cells were seeded 
on the surface of cover glass and placed in a custom recording bath filled with a modified 
Tyrode‘s solution contained (in mM): 145 NaCl, 5.4 KCl, 10 HEPES, 5 CaCl2 (pH 7.5 
with NaOH). Transfected (eGFP-expressing) cells were selected using an Axiovert 40 
CFL inverted light microscope (Zeiss). For the perforated patch configuration, a glass 
electrode (pipette resistance: 2.5-3.5 MΩ) filled with internal electrode solution 
containing (in mM): 126 KCl, 1 MgSO2, 0.5 CaCl2, 5 EGTA, 4 K2-ATP, 0.4 GTP, 25 
HEPES (pH 7.5 with CsOH), and 60 μg/ml Amphotericin B (Sigma; prepared in DMSO) 
was attached to the cell. Once a GΩ seal was achieved and access resistance was dropped 
to the level enough to record membrane potential (<15 MΩ), Tyrode‘s solution was 
replaced with the extracellular bath solution contained (in mM): 160 NaCl, 2.5 KCl, 2 
CaCl2, 1 MgCl2, 8 glucose, and 10 HEPES (pH 7.5 with NaOH). Initially, the electrical 
access to the inside of the cell was monitored using 3-s depolarizing test pulse from the 
holding potential of –80 mV to +20 mV taken every 15 s. Cells with pronounced 
rundown were discarded, and only those expressing stable currents were used. The IQ1 
and IKs currents were elicited using a family voltage protocol as described in Figure 
legend 3.4. All measurements were performed at RT (24 ± 2°C).
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CHAPTER IV 
KCNE1 PEPTIDES ACQUIRE O-LINKED GLYCANS AS A POST-
TRANSLATIONAL MODIFICATION 
 
 
ABSTRACT 
 Post-translational modifications such as N- and O-linked glycans are important 
sugar assemblies that define the biosynthetic trafficking and ultimate cellular destinations 
of their associated proteins. KCNE1 peptides have been shown to contain two putative N-
linked glycosylation sites at N5 and N26. Mutations that disrupt glycosylation at the N 
terminal sequon disrupt the efficiency of trafficking of these peptides with their cognate 
K+ channel partners. Here we report that KCNE1 peptides acquire O-linked glycosylation 
as a post-translational modification in over-expression systems and native cardiac tissues. 
We define specific threonine residues as sites of O-glycan attachment in the N-terminus 
of KCNE1. We also investigate the role of O-glycans in channel complex trafficking and 
function by comparing the cell surface expression and electrophysiological characteristics 
of wild type and O-glycan deficient mutant KCNQ1/KCNE1 channel complexes. Our 
observations suggest that the presence of O-glycans on KCNE1 peptides may likely only 
contribute to the anchoring of these channel complexes in the extracellular milieu and 
play no significant role in channel modulation. 
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INTRODUCTION 
 O-linked glycosylation is a complex protein modification that occurs on the side-
chain hydroxyl groups of serine and threonine residues (Van den Steen et al. 1998). 
Unlike their N-glycan modification counterpart, the process of O-linked glycosylation 
does not involve a consensus sequence making the prediction of O-glycan sites of 
attachment a challenging process. Additionally, not every serine or threonine residue 
found in the amino acid sequence of a protein is a substrate for this modification. The 
preferential addition of O-glycans to specific residues is dependent on various factors 
such as the tissue-specific expression of different glycosyltransferases involved in O-
glycosylation, the accessibility of side-chain hydroxyl groups and the amino acid 
environment around potential serine and threonine sites (Van den Steen et al. 1998). 
Therefore, a predictive algorithm like NetOGlyc3.1 can be used to determine whether 
specific residues on proteins are likely O-glycosylated (Julenius et al. 2005). 
 While O-linked glycosylation does not commonly occur on ion channel proteins, 
the terminal sialic acid sugars that cap O-glycan branches are also found on mature N-
glycans. Sialylation of N-glycans on Nav and Kv4.3 channels has been implicated in 
modulation of channel function (Ufret-Vincenty et al. 2001; Ufret-Vincenty et al. 2001). 
The negatively charged sialic acid sugars on N-glycans are thought to impact the voltage-
dependence of activation of cardiac Nav channels through charge effects on the voltage 
sensors as proposed by the surface potential model (Green and Andersen 1991). 
Additionally, removal of the sialic acid groups from Nav channels has been shown to 
cause channel dysfunction as observed in arrhythmogenesis (Ufret-Vincenty et al. 2001). 
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Similarly, sialic acid modifications on accessory subunits can contribute to modulation of 
the biophysical properties of ion channels. The β1 accessory subunit of the Nav/β1 
channel complex possesses sialic acid modifications that have been attributed to Nav 
channel function (Johnson et al. 2004). The Nav/β1 channel complex normally possesses 
fast activation and deactivation kinetics with a hyperpolarized shift in voltage sensitivity 
compared to Nav channels alone; the removal of sialic acid groups from β1 subunits 
results in a depolarizing shift in the voltage sensitivity of Nav1.2, Nav1.5, and Nav1.7 α-
subunits.  
 KCNE1 (E1) is the first discovered member of the KCNE family of type I 
transmembrane K+ channel β-subunits. The KCNE peptides have been shown to contain 
multiple N-glycan sequons in the extracellular N-termini (Fig. 1.5). The primary N-
glycosylation site proximal to the N-terminus is evolutionarily conserved among all 
members of the KCNE family and genetic mutations at this site have been implicated in 
disease and functional defects of channel conductance (Takumi et al. 1991; Schulze-Bahr 
et al. 1997; Larsen et al. 2001; Lu et al. 2003; Park et al. 2003). We have previously 
demonstrated that E1 protein stability and trafficking is altered in the absence of N-
glycans at the primary sequon (Figs. 3.5 and 3.6). Previous studies in our lab have shown 
that E1 may contain an additional post-translational modification that is observed as an 
incompletely digested band upon PNGase F removal of all N-glycans from mature E1 
(Chandrasekhar et al. 2006). We previously ruled out phosphorylation and ubiquitination 
of E1 as potential modifications of mature E1 (Figs. 2.3 and 2.4).  
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 KCNE3 (E3), another member of the KCNE peptide family, does not appear to 
possess additional post-translational modifications as evidenced by the complete 
digestion of mature E3 with PNGase F to unglycosylated protein (Gage and Kobertz 
2004). These results suggest the presence of a protein modification that may be unique to 
E1 peptides. Analysis of the N-terminal sequence of E1 with the NetOGlyc3.1 algorithm 
(Julenius et al. 2005), proposed multiple O-glycan attachment sites on E1. We 
subsequently tested the predictions by enzymatic deglycosylation of mature E1 with an 
O-glycosidase and determined that O-linked glycosylation of E1 contributed to the 
presence of the incomplete digestion products observed on PNGase F treatment. In order 
to define the sites of O-glycan attachment on E1, we generated chimeras of E1 with E3 
by substituting specific N-terminal regions of E1 with the corresponding regions from E3 
and by site-directed mutagenesis of potential residues on the E1 N-terminus. Finally, we 
determined whether the presence of O-glycans on E1 affected the trafficking and function 
of channel complexes containing KCNQ1 (Q1) and E1 peptides. Perforated patch clamp 
electrophysiological recordings from CHO-K1 cells co-expressing Q1 channels with 
mutant E1 peptides lacking O-glycans revealed no significant change in overall current 
compared to wild type channel complexes. Cell surface biotinylation studies indicated no 
difference in the steady state expression of mutant Q1/E1 channel complexes at the cell 
surface as compared to wild type complexes. Taken together, these observations suggest 
that, for E1 peptides, O-glycans may only play a structural role in the anchoring of Q1/E1 
complexes in the extracellular milieu. 
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RESULTS 
 Glycosylation is an important post-translational modification that affects the 
stability and forward trafficking of proteins. We previously showed that the glycosylation 
state of E1 peptides can be used to visualize their migration through the biosynthetic 
pathway (Chandrasekhar et al. 2006). Enzymatic deglycosylation of N-glycans using 
Endo H and PNGase F is a useful tool in labeling the populations of E1 peptides as either 
the ER-associated (immature) or post-ER (mature) forms. Mature E1 peptides are 
resistant to Endo H treatment; however PNGase F digestion consistently results in 
residual banding after complete removal of all N-glycans on E1 as indicated by asterisks 
on the Western blot (Fig. 4.1). To test for the presence of O-glycans, lysates from CHO 
cells co-expressing Q1/E1 were digested with an O-glycosidase in combination with 
PNGase F and neuraminidase. PNGase F digestion of E1 completely removes N-glycans 
and allows for the visualization of the residual bands; neuraminidase removes sialic acid 
sugars from N- and O-glycans and promotes efficient cleavage of O-glycans by O-
glycosidase. The PNGase F/neuraminidase/O-glycosidase (Tri) cocktail resulted in an 
almost complete loss of residual bands with an accumulation of unglycosylated E1 
protein at 16 kD, showing that mature E1 peptides acquire O-linked glycosylation as an 
additional post-translational modification.  
 Enzyme deglycosylation of mature E1 in HEK and COS-7 cells revealed similar 
residual banding upon PNGase F digestion, suggesting that the additional O-linked 
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Figure 4.1 Mature KCNE1 protein acquires O-linked glycosylation. Immunoblot 
from enzymatic deglycosylation of wild type E1 co-expressed with Q1. The samples 
were left untreated (–), digested with Endo H (Hf), PNGase F (Pf) or an enzyme cocktail 
containing PNGase F, neuraminidase and O-glycosidase (Tri) and separated by SDS-
PAGE (15%). Mature (m) samples are indicated as determined by enzymatic digestion. 
Upon treatment with Pf, incomplete cleavage products are observed and indicated by 
asterisks. Almost complete loss of partial digestion products occurs upon Tri enzyme 
treatment.   
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modifications on E1 occur in multiple over-expression cell lines (Chandrasekhar et al. 
2006). In order to establish that O-glycosylation of E1 in over-expression systems is a 
true representation of the modifications that E1 undergoes in native cells where the 
protein is localized, we obtained cardiac lysates from MK24 transgenic mice. These mice 
stably express a concatenated Q1/E1 construct denoted as MK24, by the cytoplasmic 
linkage of the C-terminus of E1 to the N-terminus of Q1. MK24 expresses a single copy 
of Q1 and E1 and was used in whole cell patch clamp experiments in transiently 
transfected CHO cells where its functional properties recapitulated those of wild type 
Q1/E1 channel complexes (Wang et al. 1998; Dilly et al. 2004). Additionally, 
biochemical analysis of the MK24 construct revealed robust expression of the fusion 
protein on a Western blot with anti-Q1 antibody (Marx et al. 2002; Dilly et al. 2004; 
Sampson et al. 2008). MK24 migrates slower than Q1 or E1 alone on 6% SDS-PAGE as 
multiple species from ~75 to 100 kD, accounting for the various glycosylated forms of 
E1 in the fusion construct (Fig. 4.2). Enzymatic deglycosylation with Endo H removed 
only immature glycans from E1, leaving the highest molecular weight species unaffected. 
PNGase F treatment results in collapse of all bands upon removal of N-glycans, with a 
faint residual product indicated by the asterisk. Tri treatment of MK24 results in an 
enhancement of the unglycosylated protein species with a decrease in intensity of the 
residual band, confirming that in native tissues, E1 peptides are post-translationally 
modified with O-glycans.  
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Figure 4.2 KCNE1 peptides in the MK24 fusion protein acquire O-glycans in mouse 
cardiac tissue. Immunoblot from enzymatic deglycosylation of MK24 Q1/E1 fusion 
protein. The samples were left untreated (–), digested with PNGase F (Pf), or an enzyme 
cocktail of PNGase F, neuraminidase and O-glycosidase (Tri) and separated by SDS-
PAGE (6%). Unglycosylated (unglyc) products are indicated as determined by enzymatic 
deglycosylation. Pf treatment removes all N-glycans on mature E1 resulting in 
accumulation of unglycosylated protein and an intermediate species indicated by the 
asterisks as previously observed in CHO cells co-expressing Q1/E1 (Fig. 4.1). Tri 
treatment results in almost complete loss of the intermediate bands, with a corresponding 
increase in accumulation of unglycosylated protein.   
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 Having confirmed the presence of O-glycans on E1 peptides in both CHO cells 
and native cardiac tissues, we next determined which amino acid residues acquired O-
glycans on the E1 N-terminus. The N-terminal sequence of E1 contains numerous 
threonine and serine residues that could function as potential O-glycan linkage sites. To 
investigate specific regions of the N-terminus where O-glycan attachment could occur, 
we generated two chimeras of E1 and E3 by substituting each of the two N-glycan sites 
from E1 with complementary sites from E3. E3 is β-subunit protein from the KCNE 
family and is homologous to E1. It undergoes only N-linked glycosylation (Gage and 
Kobertz 2004) and provides a suitable O-glycan deficient background. The positioning 
and relative distances between two of the three N-glycosylation sites on E3 are similar to 
E1 (Fig. 1.5), allowing us to generate E1/E3 chimeras without altering the positions of 
the N-glycosylation sites in E1 which are important for protein expression and stability 
(Fig. 4.3A). Expression of the chimera proteins in the absence and presence of Q1 
channels was determined to confirm their glycosylation competency and ability to 
assemble with Q1 channels (Fig. 4.3B). Unlike wild type E1, in the absence of Q1, chi1 
migrates as both mature and immature protein. This observation is reminiscent of the 
unregulated ER exit of E3 peptides (Fig. 4.4). In the absence of Q1, chi2 migrates as 
immature and unglycosylated protein. Upon co-expression with Q1 channel, wild type E1 
undergoes its characteristic shift in migration to the ~40 kD species which denotes 
mature glycosylated E1 (Chandrasekhar et al. 2006). Similarly, chi1 co-expression with 
Q1 results in a shift to a band at ~40 kD. In contrast, chi2 co-expressed with Q1 migrates  
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Figure 4.3 Generation of two KCNE1/KCNE3 chimera proteins to determine sites of 
O-glycan attachment on the KCNE1 N-terminus. (A) N-terminal amino acid sequence 
of E1 and chimeras (chi1 and chi2) depicting the N-terminal regions of E3 introduced 
into E1. N-glycosylation sites are color coded orange for E1 and blue for E3. N-
glycosylation sites are underlined while putative O-glycan attachment sites are 
highlighted in bold face. (B) Immunoblot of wild type E1 (wt) and chimera peptides (chi1 
and chi2) expressed in the absence or presence of Q1 K+ channels. Samples are separated 
by SDS-PAGE (15%). Mature (m), immature (imm) and unglycosylated (ungly) samples 
are indicated based on mobility shifts compared to wt E1.  Co-expression with Q1 results 
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in slower migration of chi2 as an intermediate cluster of bands indicated by an open 
arrowhead. (C) Immunoblots from enzymatic deglycosylation of chi1 and chi2 co-
expressed with Q1. Samples were left untreated (–), digested with Endo H (Hf), PNGase 
F (Pf) or enzyme cocktail (Tri) and separated by SDS-PAGE (15%). Intermediate cluster 
of bands indicated by open arrowhead in panel B are identified as mature chi2 protein. 
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Figure 4.4 KCNE3 peptides acquire mature glycans in the presence and absence of 
KCNQ1 K
+
 channel partners. Immunoblot of CHO cell lysates expressing E3 alone or 
co-expressed with Q1. In the absence of Q1, E3 peptides acquire mature glycans as 
indicated on the blot as a higher molecular weight species. This shift is more pronounced 
upon co-assembly with Q1 when the majority of the E3 peptides acquire mature glycans. 
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faster (~30 kD) than mature wild type E1, indicated by the open arrowhead. Enzymatic 
deglycosylation of the chimeras co-expressed with Q1 confirms the various glycosylation 
states of the protein (Fig. 4.3C). For Q1/chi1, Endo H digestion results in collapse of only 
faint immature chi1 bands to unglycosylated protein while PNGase F treatment results in 
collapse of mature chi1 to incompletely digested bands as observed for wild type E1. As 
with wild type E1, tri treatment of Q1/chi1 samples results in almost complete loss of 
residual banding. For Q1/chi2, the 30 kD species of chi2 is resistant to Endo H treatment 
but completely collapses to unglycosylated protein upon PNGase F digestion without the 
appearance of any residual bands. These observations show that chi2 acquires mature N-
glycans and the O-linked glycosylation sites are located in the N-terminal region of E1 
that has been replaced in chi2 (residues 1 – 25).  
 In the absence of defined consensus sites for the attachment of O-glycans on 
proteins, we refined the NetOGlyc3.1 sequence analysis of E1 residues 1 – 25 which 
returned a prediction for two potential O-linked glycosylation sites at threonine residues 6 
and 7 (T6 and T7) (Fig. 4.5). T7 is necessary for the transfer of a core N-glycan to 
asparagine 5, and a genetic mutation at this residue (T7I) that prevents N-glycosylation at 
the first sequon is associated with Long QT Syndrome (LQTS) (Schulze-Bahr et al. 
1997). Therefore, to prevent disruption of N-glycan attachment at N5, we mutated T6 to 
phenylalanine (T6F), a hydrophobic substitution severe enough to disrupt O-glycan 
attachment at both T6 and T7 (Hamby and Hirst 2008). Protein expression and enzyme 
deglycosylation of T6F in the presence of Q1 channels was visualized by Western blot 
(Fig. 4.6A). Co-expression of T6F with Q1 results in maturation of E1 although the  
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Figure 4.5 Predictive analysis for O-glycan attachment sites on KCNE1 N-terminal 
residues. Summarized results from NetOGlyc 3.1 server reveals residues predicted to 
acquire O-glycan modifications in the first 25 amino acid sequence of E1. Based on G-
score and I-score values, T6 and T7 are the best predicted residues to be modified.  
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Figure 4.6 T6F mutation prevents O-linked glycosylation of KCNE1 peptides. (A, B, 
C) Immunoblots of enzymatic deglycosylation of threonine mutant E1 peptides co-
expressed with Q1. The samples were left untreated (–), digested with Endo H (Hf), 
PNGase F (Pf) or enzyme cocktail (Tri) and separated by SDS-PAGE (15%). Mature (m), 
immature (imm) and unglycosylated (ungly) samples are indicated as determined by 
enzymatic deglycosylation. Pf digestion of mature T6F in panel A results in complete 
collapse to unglycosylated protein with no trace of residual bands. In panel B, enzymatic 
deglycosylation of T6A mutant reveals characteristic residual banding as observed with 
wild type E1 in Figure 4.1. In panel C, T7A abolishes almost all O-glycan attachment to 
E1 peptides as evidenced in Pf lane where mature E1 peptides collapse to the 
unglycosylated product. 
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efficiency of N-glycosylation is reduced. This observation is not unusual as hydrophobic 
amino acid substitutions around N5 have been shown to reduce the efficiency of N-
glycosylation at that site (Fig 3.1). Endo H digestion results in the collapse of faint 
immature protein while the multiple mature glycan species are resistant to the enzyme. In 
contrast, PNGase F treatment of Q1/T6F samples results in the complete collapse of 
mature T6F to the unglycosylated form without any residual bands, indicating the 
absence of O-glycans on T6F peptides. Since the T6F mutation does not distinguish 
between the preferential addition of O-glycans to T6 or T7, we also generated single site 
mutations at T6 and T7 to the less severe hydrophobic residue alanine and evaluated their 
glycosylation pattern through the characteristic enzymatic deglycosylation previously 
used for T6F (Fig. 4.6B, C). We observed the loss of O-glycans from the T6A mutant 
only upon treatment with the enzyme cocktail. Interestingly, the T7A mutant afforded 
complete loss of glycosylated species upon PNGase F digestion. This result suggests that 
T7 functions as the major site that acquires O-linked glycans during the biosynthetic 
processing of E1 peptides.  
 We then determined whether the T6F mutation affected the trafficking and 
biophysical properties of Q1/E1 channel complexes. To directly measure the plasma 
membrane distribution of the T6F E1 peptides co-expressed with Q1 channel subunits, 
we used cell surface biotinylation. This approach allows us to measure whether the 
absence of O-glycans alters Q1/E1 complex trafficking to the cell surface. Cells 
expressing wild type and T6F mutant Q1/E1 complexes were labeled with a membrane-
impermeant, amine-reactive biotin reagent at 4°C to prevent membrane recycling and 
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minimize labeling of intracellular proteins. The biotinylated proteins were isolated with 
streptavidin beads (Fig. 4.7A). To verify that the cells remained intact during 
biotinylation, we monitored the labeling of an ER-resident protein – calnexin and 
subtracted out the background intracellular labeling to calculation the cell surface 
expression of E1 peptides (Fig. 4.7B). We observed no significant difference in the cell 
surface labeling of wild type (28 ± 4%) versus T6F E1 (23 ± 2%) peptides in the presence 
of Q1 channels suggesting that the lack of O-glycans does not adversely affect the 
biosynthetic processing and trafficking of mutant Q1/E1 channel complexes.  
 To determine whether the T6F mutation altered the biophysical properties of 
Q1/E1 channel complexes, we measured current elicited at various depolarizing voltages 
using perforated patch clamp of CHO-K1 cells co-expressing Q1 and either wild type E1 
or T6F. Families of currents generated for Q1/E1 and Q1/T6F show no significant 
difference in current amplitude (Fig. 4.8A). Tail current analysis additionally revealed no 
change in the midpoint of activation (V1/2) of Q1/T6F as compared to Q1/E1 channel 
complexes (Fig. 4.8B). 
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Figure 4.7 Cell surface distribution of wild type versus T6F mutant KCNE1 
peptides. (A) A representative immunoblot of wild type and T6F mutant E1 peptides 
expressed in CHO cells with Q1 channel subunits. Transfected cells were labeled as 
described for CHO cells. (B) Quantification of the biotinylated E1 proteins. The 
percentage of biotinylated protein was calculated by dividing the band intensities in the 
biotinylated lane by the band intensities in the one-fifth total input lane, which were 
multiplied by five. The error bars are standard error measurement (S.E.M.) from three 
immunoblots. The dotted line indicates background biotinylation, which was calculated 
from calnexin staining (6 ± 1%). 
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Figure 4.8 Electrophysiological properties of KCNQ1 channels co-expressed with 
wild type or T6F mutant KCNE1 peptides in CHO cells. (A) representative families of 
IKs current traces recorded from CHO cells using the following voltage protocol: 
membrane was held at –80 mV, subjected to 3-s depolarizing pulses ranging from –100 
mV to +60 mV, followed by 1-s pulses at –30 mV. Cells were transfected with a Q1 
partnered with either wt (+WT) or mutant (+T6F) E1 cDNA. T6F mutant IKs channels 
generated a typical slowly activating voltage-dependent current at depolarizing potentials 
above –40 mV. (B) Voltage dependence of activation: activation curves were obtained by 
plotting the normalized tail currents as a function of the pre-pulse potential. Values for 
the midpoint of activation (V1/2) were obtained by fitting with the Boltzmann equation 
(solid lines). No significant difference was observed between the V1/2 values of wild type 
and mutant IKs current. 
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DISCUSSION 
 We investigated the presence of an additional post-translational modification on 
E1 by the enzymatic removal of glycans from mature E1 peptides. Incomplete digestion 
products identified by PNGase F deglycosylation of E1 were observed to be sensitive to 
O-glycosidase treatment, indicating the presence of O-glycans on E1. We generated 
specific N-terminal chimeras of E1 and E3 and treated them with a deglycosylation 
enzyme cocktail of PNGase F, neuraminidase and O-glycosidase to determine specific 
regions of the E1 N-terminus where O-glycan attachment residues were located. Using 
predictions from the NetOGlyc3.1 algorithm and site-directed mutagenesis, we then 
determined that E1 acquires O-glycans at one or both threonine residues located within 
an N-glycosylation consensus site. O-linked glycosylation was only observed on mature 
E1 as PNGase F digestion of immature E1 does not yield any incomplete digested 
products (Fig. 2.2). Co-expression of E1 with Q1 is required to facilitate progression of 
E1 peptides through the biosynthetic pathway to the Golgi compartments where the 
mature modification of N-glycans and attachment of O-glycans are catalyzed (Roth et al. 
1986).  
 Removal of mature N-glycans upon PNGase F digestion of E1 reveals the 
presence of additional modifications on E1 otherwise masked in the heterogeneous 
distribution of mature protein on an SDS-PAGE. Endo N-acetyl galactosaminidase is a 
specific O-glycosidase which catalyzes the removal of unsubstituted Gal β (1-3) GalNAc 
units from serine or threonine residues. As sialylated O-glycans are inefficient substrates 
for O-glycosidase digestion (Van den Steen et al. 1998), terminal sialic acid substituents 
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on O-glycans were removed with neuraminidase. Therefore, we created a deglycosylation 
enzyme cocktail of PNGase F, neuraminidase and O-glycosidase to determine whether 
there was a change in the mobility of the incomplete digested products. The susceptibility 
of E1 to endo N-acetyl galactosaminidase suggests the predominance of O-linked glycans 
that are sialylated with a core Gal β (1-3) GalNAc sugar unit.  
 The O-glycosidase used in the characterization of the O-glycan modifications on 
E1 is specific for unsubstituted N-acetyl galactosamine residues. We consistently observe 
that upon O-glycosidase treatment of E1 there are very faint residual bands that do not 
collapse even on prolonged enzyme treatment (Figs. 4.1 and 4.2). One possible 
explanation for the residual banding could be the presence of other substituents on the N-
acetyl galactosamine core sugar that renders the O-glycosidase ineffective in hydrolyzing 
the O-glycan. The neuraminidase used to cleave the terminal sialic acid substituents 
preferentially removes α2-3 and α2-6 linkages over α2-8 linkages. As a result, any α2-8 
sialic acid groups on O-glycans would reduce the efficiency of O-glycosidase hydrolysis 
resulting in the persistent residual bands observed upon enzyme digestion of E1.  
 The cellular distribution of glycosyl-transferases involved in O-glycan 
modification varies by cell-type (Roth et al. 1986). We routinely observed incomplete 
digestion products on PNGase F digestion of mature E1 in CHO, HEK and COS-7 cells 
(Chandrasekhar et al. 2006). In order to verify that O-glycosylation of E1 was not an 
artifact of the over-expression cell systems we used in biochemical investigation of E1 
trafficking, we performed enzymatic deglycosylation on tissue lysates from transgenic 
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mouse hearts expressing the MK24 Q1/E1 fusion protein. The MK24 protein was used in 
functional studies of Q1/E1 assembly and stoichiometry and recapitulated the biophysical 
properties of naturally associating Q1/E1 channel complexes (Wang et al. 1998). On 
SDS-PAGE, the MK24 protein migrated at a combined molecular weight of each of the 
Q1 and E1 subunits it contains. However, multiple bands observed on the blot correspond 
to the various glycosylated forms of E1 in the fusion protein (Sampson et al. 2008). 
PNGase F digestion of N-glycans from the MK24 fusion protein resulted in a difference 
in distribution of the residual digestion products compared to CHO cells (Figs. 4.1 and 
4.2). It is likely that this disparity in the migration of the digestion products was a result 
of the difference in the SDS-PAGE used (15% in Fig. 4.1 versus 6% in Fig. 4.2) making 
it harder to accurately resolve the small molecular weight variations in some of the 
residual digestion products. Another explanation for this observed difference could be the 
subtle variations in O-glycan modification that are unique to cardiac cells. It is also 
possible that the MK24 fusion protein does not acquire all the O-glycan modifications we 
observe in CHO cells. Through these observations, we established that O-glycosylation 
of E1 occurs in both over-expression systems and native cardiac tissues. 
 The relative location of O-linked glycosylation sites on E1 was determined by 
generating two chimeras of E1 with N-terminal regions substituted from the homologous 
peptide, E3. Enzymatic deglycosylation established that E3 acquires only N-glycans as a 
protein modification (Gage and Kobertz 2004). The systematic substitution of two 
regions of the N-terminus of E1 with E3 preserves the positioning of the N-glycan sites in 
wild type E1 which are important for E1 protein expression and trafficking. The chimera 
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proteins exhibit different migration patterns on SDS-PAGE in the absence and presence 
of Q1 channels. The chi1 chimera appears to acquire mature glycosylation even in the 
absence of Q1, unlike its wild type E1 counterpart. Unpublished results have shown that 
wild type E3 peptides acquire mature glycosylation even in the absence of Q1 channels 
(Fig. 4.4). It appears that the E3 N-terminal region substituted in chi1 allows the protein 
to retain some of the trafficking characteristics of E3. On the other hand, the chi2 mutant 
behaves similar to wild type E1 in that it acquires mature glycans only in the presence of 
Q1. Mature chi2 migrates faster than mature wild type E1, suggesting that chi2 may have 
impaired N-glycosylation as a result of the substitution of the N-terminal sequon in E1. 
Previous work shows that efficient co-translational N-glycosylation of E1 at the first 
sequon is an important determinant in subsequent post-translational N-glycosylation at 
the second sequon (Chapter III). Insertion of E3 N-terminal sequon may have reduced the 
overall efficiency of N-glycosylation of chi2. However, co-expression of Q1 channel 
results in an increased efficiency of chi1 and chi2 maturation and suggests there is 
otherwise normal biosynthetic processing of the chimera proteins. 
 Enzymatic deglycosylation of the E1/E3 chimera proteins place the O-linked 
glycosylation sites on E1 in the region contained within residues 1 through 25. Predictive 
sequence analysis of the residues using the NetOGlyc3.1 server revealed two potential O-
linkage sites at T6 and T7 (Fig. 4.5). These residues form part of the N-glycosylation 
sequon at asparagine 5 (N5). T7 is implicated in LQTS and cannot be mutated because of 
its role in glycan transfer to N5. Analyzing efficient amino acid substitutions at T6 
determined that a phenylalanine at T6 would most severely affect the O-linked 
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glycosylation at both T6 and T7. However, the downside to this mutation is the reduced 
efficiency of N-glycosylation of the T6F mutant as a result of an increase in the 
hydrophobic environment around N5. A hydrophobic environment around the N-terminal 
sequon has an adverse effect on the overall efficiency of E1 N-glycosylation (Chapter III) 
and is likely why T6F migrates as multiple mature N-glycosylated forms (Fig. 4.6).  
 Recent enzymatic deglycosylation characterization of a small single 
transmembrane spanning protein Opalin, revealed the presence of N- and O-glycans in 
close proximity to each other in the extracellular N-terminal domain of the protein 
(Yoshikawa et al. 2008). Using O-glycosidase in combination with PNGase F and 
neuraminidase, the authors identified the presence of small sialylated O-glycans attached 
to Opalin. In order to determine the exact sites of O-glycan attachment, the authors used 
alanine-substitution of specific threonine residues. One particular threonine to alanine 
substitution is located at the terminal position in a consensus site for N-glycosylation (N-
T-TN-T-A). In addition to preventing O-glycosylation, the alanine substitution disrupts 
N-glycosylation at the asparagine residue. E1 contains an identical N-glycan sequon at 
N5 (N-T-T). To circumvent the disruption of N-glycosylation at N5 by substitution of T7, 
we engineered the T6F mutation. The caveat to this approach is that the introduction of a 
hydrophobic residue within an N-glycan consensus site reduces the N-glycosylation 
efficiency of T6F peptides. This effect is evident in the presence of multiple mature 
glycosylated forms of T6F. Less severe hydrophobic mutations, T6A and T7A, prevent 
O-glycosylation only at T6 or T7 respectively (Hamby and Hirst 2008). We then used 
enzymatic deglycosylation of the T6A and T7A mutants to determine which site 
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specifically acquires O-glycans (Fig. 4.6). Enzymatic deglycosylation reveals that both 
T6 and T7 acquire O-glycans; however, T7 appears to be the predominately modified 
site. It is interesting to note the proximity of the N- and O-glycan attachment sites in E1. 
One of the two threonine residues considered to be involved in O-glycan linkage is also 
part of an N-glycosylation consensus sequence (T7). It appears that there is no spatial 
interference on the attachment of O-glycans in the presence of N-glycans as we observe 
that mature E1 peptides efficiently acquire O-glycans. Previous work done on the mouse 
hepatitis virus membrane protein showed that O-glycosylation occurs efficiently on the 
hydroxylamino acid of an exogenously introduced N-glycosylation site (de Haan et al. 
1998). The prior addition of N-glycans to the protein does not impede subsequent 
addition of O-glycans. It is likely that the positioning of O-glycans within the conserved 
N-glycan sequon contributes to the structural integrity of the N-terminus of E1 peptide. 
O-glycans are also involved in proper cell surface expression of proteins like 
Glycophorin A (Remaley et al. 1991), so their presence might contribute to the overall 
protein stability and expression of E1 peptides. 
 The necessary desialylation of O-glycans on E1 to facilitate O-glycosidase 
hydrolysis establishes the predominance of sialic acid sugars on a majority of O-glycans 
on E1. The importance of sialic acid moieties in Na+ channel function has been 
determined. Ufret-Vincenty et al. established that the glycosylation state of the cardiac 
sodium channel affected both the current density and voltage-dependence of channel 
conductance (Ufret-Vincenty et al. 2001). Neuraminidase digestion of terminal sialic 
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acids from N-glycans present on Na+ channels reduced the overall measured current 
density and elicited a positive shift in the midpoint of activation. 
 Unlike Na+ channels, Q1 channels do not acquire any kind of glycosylation. 
Therefore, any predicted effect of glycosylation on channel trafficking and function 
would be a result of changes to N- or O-glycans on E1. We then determined whether O-
glycans on E1 had an effect on Q1/E1 channel trafficking by comparing the cell surface 
distribution of wild type Q1/E1 to Q1/T6F complexes (Fig. 4.7). We observed no 
significant difference in the percentage of biotinylated wild type or mutant E1 peptides. 
We also observed no significant effect from the lack of O-glycans on channel function by 
comparing biophysical parameters such as voltage sensitivity and midpoint of activation 
between the wild type and mutant channels. These observations strongly suggest that the 
O-glycans on E1 do not exert any effect on channel modulation. .  
 The discovery of a novel post-translational modification, O-linked glycosylation, 
on E1 peptides enhances our understanding of how glycosylation plays an important role 
in the stability and trafficking of E1 peptides. Since this modification has only been 
identified in E1 peptides so far, it would be interesting to determine whether other 
members of the KCNE peptide family acquire O-glycans. KCNE4 (E4) is the only other 
member of the KCNE family that possesses a hydroxylamino acid at the X-position 
within its N-terminal sequon. E4 transcripts are present in the heart and E4 peptides are 
thought to contribute to the generation of IKs currents (Lundquist et al. 2005; Morin and 
Kobertz 2007; Manderfield and George 2008). The presence of O-glycans on other 
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KCNE peptides would suggest a role for these glycans in the generation of assembly and 
trafficking-competent K+ channel complexes that function in the heart.   
134 
 
EXPERIMENTAL PROCEDURES 
MK24 cardiac lysates were generously provided by R. Kass. Lysates were prepared as 
previously described (Marx et al. 2002). 
Plasmids and cDNAs—Human Q1 and E1 were subcloned into pcDNA3.1 (–) 
(Invitrogen). All E1 constructs (wild type and chimeras) contained a C-terminal HA 
(YPYDVPDYA) epitope tag attached to the C-terminus of E1 through an SGSG linker. 
Chimeras of E1 and E3 were generated by cassette mutagenesis. The T6A, T6F and T7A 
point mutations were introduced into E1 using QuikChange ® site-directed mutagenesis 
(Stratagene). 
Cell Culture and Transfections—Chinese Hamster Ovary-K1 (CHO) cells were cultured 
in F-12K nutrient mixture (Invitrogen), supplemented with 10% fetal bovine serum 
(Hyclone) and 100 units/ml penicillin/streptomycin (Invitrogen). Cells were plated at 60–
75% confluency in 35-mm dishes. After 24 h, the cells were transiently transfected at 
room temperature (RT) with Lipofectamine (Invitrogen) 8 μl per mL of Opti-MEM 
(Gibco-Invitrogen) and returned to fresh culture media after 6 h. DNA ratios (in μg): 
E1/empty pcDNA 3.1 plasmid: 1.5/0.75; Q1/E1, Q1/T6F or Q1/chimeras: 0.75/1.5. Cells 
were lysed 48 h post-transfection for Western Blot analysis. 
Cell Lysis and Western Blot Analysis—The cells were washed in ice-cold PBS (3 x 2 ml) 
and lysed at 4°C in RIPKA lysis buffer (10 mM Tris·HCl, pH 7.4, 140 mM NaCl, 10 mM 
KCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate), 
supplemented with protease inhibitors, 1 mM phenylmethylsulfonyl fluoride, and 1 μg/ml 
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each of leupeptin, pepstatin, and aprotinin. For expression gels, CHO cells were lysed in 
250 μl of RIPKA buffer. Cell debris was pelleted in a microcentrifuge (16,100 x g for 10 
min at room temperature). The supernatants were diluted with SDS-PAGE loading buffer 
containing 100 mM dithiothreitol, separated on a 15% SDS polyacrylamide gel, and 
transferred to nitrocellulose (0.2 μ; Schleicher & Schuell). The membranes were blocked 
in blocking buffer (5% nonfat dry milk in Tris-buffered saline containing 0.2% Tween-20 
(TBS-T)) for 30 min at RT and then incubated with rat anti-HA (Roche Applied Science) 
(1:750) in blocking buffer overnight at 4°C. For MK24 lysates, blots were incubated with 
rabbit anti-Q1 (Sigma) (1:1000) in blocking buffer for 2 h at RT. The membranes were 
washed in TBS-T (4 x 5 min) and incubated with goat anti-rat horseradish peroxidase-
conjugated antibody (Santa Cruz Biotechnology, Inc.) (1:2000) or goat anti-rabbit 
horseradish peroxidase-conjugated antibody (Cell Signaling Technology) (1:3000) in 
blocking buffer for 30 min at RT. The membranes were subsequently washed with TBS-
T (4 x 5 min). Horseradish peroxidase-bound proteins were detected by 
chemiluminescence using SuperSignal West Dura Extended Duration Substrate (Pierce) 
and a Fujifilm LAS-3000 CCD camera. 
Enzymatic Deglycosylation Analysis—Cell lysates (30 μl) were digested with Endo Hf (3 
μl) or PNGase F (3 μl) (New England BioLabs, Inc.) or an enzyme cocktail containing 
PNGase F/neuraminidase/O-glycosidase (3 μl/3 μl/1 μl) for 1 h at 37°C (Neuraminidase; 
O-glycosidase: Roche). The samples were then raised to 100 mM dithiothreitol and 3.5% 
SDS before resolving by SDS-PAGE (15% gel) and analyzed by Western blot. 
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Enzymatic deglycosylation of MK24 cardiac lysates—MK24 lysates (20 μl) were 
digested with Endo Hf (5 μl) or PNGase F (5 μl) or an enzyme cocktail containing 
PNGase F/neuraminidase/O-glycosidase (5 μl/5 μl/5 μl) for 1 h at 37°C. Lysates were 
raised to 100 mM dithiothreitol and 5% SDS before resolving by SDS-PAGE (6% gel) 
and analyzed by Western blot.   
Cell Surface Biotinylation—Cells were rinsed with ice cold PBS2+ buffer (four times with 
2 ml; PBS containing 1 mM MgCl2, 0.1 mM CaCl2) at 4°C to arrest membrane 
internalization. The cells were then incubated with 1 mg/ml sulfo-NHS-SS-biotin (Pierce) 
in PBS2+ buffer twice for 15 min at 4°C. To quench the excess biotinylation reagent, the 
cells were washed quickly (three times with 2 ml) with quench solution (PBS2+ 
containing 100 mM glycine) and then incubated with quench solution twice for 15 min at 
4°C. The cells were lysed in RIPKA buffer for 30 min at 4°C. Cell debris was removed 
by centrifugation (16,100 x g for 10 min at 4°C). Total protein in each sample was 
quantitated by BCA analysis. Of these samples, 75 μg of total protein was separated by 
affinity chromatography on 25 μl of Immunopure® immobilized streptavidin beads 
(Pierce) overnight at 4°C, whereas 15 μg was saved as an input control to determine the 
percentage of biotinylated proteins. The beads were washed (three times with 500 μl) in 
0.1% SDS wash buffer (10 mM Tris·HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% 
SDS). Biotinylated proteins were eluted from the beads using 2xSDS-PAGE loading 
buffer with 200 mM dithiothreitol for 15 min at 55°C. The inputs and eluted proteins 
were resolved by SDS-PAGE (15% gel) and analyzed by Western blot. The images of 
nonsaturated bands were captured on a Fujifilm LAS-3000 CCD camera, and the band 
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intensities were quantitated using MultiGauge V2.1 software (FujiFilm). An ER-resident 
protein, calnexin, was used as a control to determine the percentage of cell rupture that 
occurred during the labeling process. Background cell lysis was quantitated as a ratio of 
biotinylated calnexin protein to total input calnexin. The percentage of E1 protein on the 
cell surface was calculated from the ratio of avidin-bound protein to total input protein 
after background lysis subtraction. 
Perforated Patch Whole-Cell Recordings—For electrophysiological experiments, CHO-
K1 cells were transiently transfected (in µg per dish) with 0.75 Q1 (wt) and 1.5 E1 (wt or 
mutant) plus 0.25 pEGFP-C3. Cells were used 24-48 h post-transfection. Currents were 
recorded in the standard whole-cell perforated patch configuration as described (Lvov et 
al. 2010). Briefly, on the day of the experiment, cells were seeded onto glass coverslips 
and placed in a recording chamber filled with extracellular solution containing (in mM): 
160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 8 glucose, and 10 HEPES (pH 7.5 with NaOH). 
For the perforated patch configuration, a glass electrode (pipette resistance: 2.5-3.5 MΩ) 
filled with electrode solution containing (in mM): 126 KCl, 1 MgSO2, 0.5 CaCl2, 5 
EGTA, 4 K2-ATP, 0.4 GTP, 25 HEPES (pH 7.5 with CsOH), and 60 μg/ml Amphotericin 
B (Sigma; prepared in DMSO) was attached to the transfected (eGFP-expressing) cell. 
Electrical access to the inside of the cell was monitored using 3-s depolarizing test pulse 
from the holding potential of -80 mV to +20 mV taken every 15 s. Once the access 
resistance was dropped to a level suitable to record the membrane potential (<10 MΩ), 
IKs currents were assayed for native-like function using a pulse protocol to generate a 
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family of traces as described in Figure legend 4.8. All measurements were performed at 
room temperature (24 ± 2°C). 
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CONCLUSIONS 
 The work presented in this thesis determined the significance of the correct 
assembly and trafficking of KCNQ1/KCNE1 (Q1/E1) channel complexes for their proper 
physiological function. Our observations explain how deficiencies in the biosynthesis of 
K+ channel complexes, either by impaired assembly or aberrant trafficking, can be 
correlated to Long QT Syndrome.  In Chapter II, we described how the forward 
trafficking and efficient cell surface expression of KCNE1 (E1) peptides was dependent 
on co-expression of KCNQ1 (Q1) channels. Our observations helped to explain 
conflicting observations about the trafficking of E1 peptides and confirmed the 
endoplasmic reticulum (ER) as the cellular location for Q1/E1 complex formation 
(Krumerman et al. 2004; Chandrasekhar et al. 2006).  
 Glycosylation has been shown to be important in the expression, stability and 
trafficking of K+ ion channels such as Shaker and hERG (Petrecca et al. 1999; Gong et al. 
2002; Khanna et al. 2004). N-glycosylation of these channels increases the overall 
stability of individual subunits promoting efficient folding and assembly into functional 
channels that traffic to the cell surface. Since Q1 does not acquire glycosylation, any 
predicted effects of glycosylation on channel function would be due to the presence of 
glycans on the KCNE β-subunits. In Chapter III, we determined the importance of the 
conserved N-terminal glycosylation sites in E1 peptides in generating correctly 
functioning Q1/E1 channel complexes. Glycosylation did not significantly impact protein 
stability of E1 peptides as measured by the kinetics of decay of wild type and 
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glycosylation-deficient E1 peptides. However, glycosylation of E1 did influence the 
forward trafficking of Q1/E1 complexes and their function at the cell surface. Our 
observations in Chapter III suggest a novel mechanism by which glycosylation deficiency 
promotes Q1/E1 channel dysfunction. These findings can be applied to investigate the 
mechanism of co- and post-translational glycosylation of other KCNE peptides. For 
instance, since KCNE3 has three putative sequons, which sites acquire N-glycans co- or 
post-translationally? In contrast, KCNE4 (E4) has only one putative sequon. Does 
interruption of N-glycosylation of E4 affect its stability and ability to associate efficiently 
with K+ channels? 
 The presence of O-glycan modifications on E1 is a novel discovery for ion 
channel proteins. In Chapter IV, we determined potential O-glycan linkage sites at two 
threonine residues (T6 and T7) located within a highly conserved N-glycan sequon. Other 
studies have demonstrated the functional importance of sialylated glycans on cardiac Nav 
ion channels and their associated β1 subunits (Ufret-Vincenty et al. 2001; Johnson et al. 
2004). Biochemical and electrophysiological studies were used to determine whether O-
glycan deficiency impairs efficient Q1/E1 complex trafficking and plasma membrane 
localization. The proximity of N- and O-glycans could imply a cooperative effect by both 
modifications on the stability and trafficking of Q1/E1 complexes. Similar to E1, 
sequence analysis of the KCNE family revealed that E4 contains hydroxylamino acids 
within its N-terminal sequon that are predicted to acquire O-glycans. RT-PCR analysis 
shows that E4 transcripts are abundantly expressed in the human heart (Bendahhou et al. 
2005; Lundquist et al. 2005). E4 peptides can also associate with Q1/E1 channel 
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complexes to contribute to IKs currents (Morin and Kobertz 2007). Taken together, these 
observations suggest a potential role for sialylated O-glycans on KCNE peptides in the 
maintenance of cardiac rhythm. 
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FUTURE DIRECTIONS 
Does the processing and trafficking of KCNE peptides in native cells mimic our 
observations in over-expression systems? 
 While we have used epitope-tagged constructs in over-expression cell systems for 
the biochemical characterization of KCNE1 (E1) peptides, it would be advantageous to 
examine the trafficking and biosynthetic processing of K+ channel complexes in their 
native environments. The lack of good-quality commercially-available native antibodies 
presents a challenge to the investigation of KCNE peptides in native cells.  
 One alternative approach could be to use the presence of glycan modifications on 
KCNE peptides to investigate their glycosylation states, cell surface expression and 
association with K+ channel partners. Previous work in the lab has shown the feasibility 
of incorporating non-native sugars into N-glycans on KCNE peptides. Using thiol-
derivatized acylated sialic acid as precursors, we can exploit the native cellular 
processing of sugars to guide the incorporation of this non-native sugar into N- and 
possibly O-glycans attached to KCNE peptides. The incorporation would introduce a 
thiol group on the sugar that can be chemically modified by labeling with different probes 
specific for K+ channel/KCNE complexes.  
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Are other KCNE peptides glycosylated co- or post-translationally?  
 N-glycosylation is a post-translational modification common to all members of 
the KCNE family, particularly at the conserved N-terminal sequon. The study of co- and 
post-translational glycosylation of E1 in Chapter III prompts the question of whether 
other KCNE peptides acquire co- and post-translational N-glycosylation and the 
relevance to disease. How does the T8A mutation in KCNE2 (E2) impact assembly and 
trafficking of the peptide in a channel complex? Does the T8A mutation impact 
glycosylation of the other site in E2? We could examine these questions using kinetic 
analyses similar to those in Chapter III. 
 Since transcripts for all the KCNEs have been identified in the heart, we could 
determine the impact of glycosylation deficiency on the efficiency of channel complex 
assembly. Does the interruption of glycosylation of KCNE1 peptides improve KCNQ1 
channel assembly with other KCNEs? This could have serious implications in cardiac 
tissue where generation of IKs current is important.  
 
Are O-glycan modifications present on other KCNE peptides? Is there a functional role 
for O-glycans in K
+
 channel modulation?  
 Preliminary electrophysiological recordings of O-glycan deficient Q1/E1 channel 
complexes showed no significant change in currents compared to wild type Q1/E1 
channel complexes. Additionally, biochemical analysis by cell surface biotinylation of 
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Q1/E1 complexes revealed that there is no trafficking defect associated with O-glycan 
deficiency.  
 Similar to E1, KCNE4 (E4) possesses hydroxylamino residues within its N-
terminal sequon. We could determine whether O-glycans are present on E4 peptides. 
Using biochemical and electrophysiological techniques, we could determine the role of 
O-glycans in the assembly, trafficking and function of E4/K+ channel complexes, 
particularly the heteromeric complex of Q1/E1/E4 which has been shown to generate IKs 
currents (Morin and Kobertz 2007). We could investigate functional effects of O-glycans 
by the enzymatic deglycosylation of CHO cells expressing Q1/E1/E4 channel complexes 
and subsequent patch clamp of the cells. It would also be interesting to determine 
whether the presence of wild type E4 had an effect on the assembly of O-glycan deficient 
E1 (T6F) in a heteromeric complex with Q1 channels and could rescue the reduction in 
current that we observe with Q1/T6F complexes. The presence of O-glycans on E4 
peptides could suggest a potential role for sialic acid modifications in the proper 
trafficking and function of K+ channel/KCNE complexes in the heart.  
 In all, the work done in this thesis examining the assembly and trafficking of a 
specific K+ channel/KCNE complex extends the understanding of how the efficient 
biosynthetic processing of ion channel complexes is important in their proper 
physiological function. Additionally, the post-translational modifications on KCNE 
peptides have been implicated in disease and suggest novel mechanisms for ion channel 
dysfunction. Our biochemical investigation of KCNQ1/KCNE1 K+ channel complexes 
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prompts questions that can enhance our understanding of the mechanisms responsible for 
ion channel disease.  
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